73 results on '"K. Bozkurt"'
Search Results
2. Olfactory dysfunction in primary Sjogren’s syndrome and its correlation with dry eye
- Author
-
Yunus E. Topan, Banu Bozkurt, Sema Yılmaz, Çağdaş Elsürer, Sona Gorcuyeva, and Mete K. Bozkurt
- Subjects
Otorhinolaryngology ,RF1-547 - Published
- 2021
- Full Text
- View/download PDF
3. Morphometric Development of Sphincter of Oddi in Human Fetuses During Fetal Period: Microscopic Study
- Author
-
E. Hilal Evcil, Ceren Uğuz, Kemal K. Bozkurt, Kadir Desdicioğlu, and Mehmet A. Malas
- Subjects
Sphincter of Oddi ,human fetus ,morphometry ,microscopy ,fetal development ,Medicine - Abstract
Objective: In this study, morphometric developments of the sphincter of Oddi in human fetuses were observed. Material and Methods: We observed 113 human fetuses consisting of 67 male and 46 female subjects, whose ages varied between 14 to 40 weeks who showed no signs of any pathology or anomaly externally. The common external measurements of fetuses were carried out, followed by abdominal dissection to determine where the sphincters of Oddi were localized within the duodenum and pancreas. Histological specimens of tissue samples were gathered from the inner wall of the duodenum where it was assumed that the sphincters of Oddi had been localized. The parameters of total external diameters, lumen diameters, wall thickness, diameters of ductus choledochus and ductus pancreaticus, and the distance between these two structures, which are also known as the origins of the sphincter of Oddi, were measured by using a light microscope. The standard deviations of the measurements were calculated for each gestational week and trimester. Results: The calculations suggested that there were statistically significant correlations between gestational age and all of the other parameters with the exception of the ductus choledochus (p0.05).Conclusion: The data we collected in our study were considered as useful for the evaluation of the development of the sphincter of Oddi area and fetal stage.
- Published
- 2012
4. Charge Transport in Bifidobacterium animalis subsp.lactis BB-12 under Various Atmospheres
- Author
-
H. S. Bozkurt, O. Özdemir, Ahmet Altındal, K. Bozkurt, Z. Avdan, and Cenk Denktaş
- Subjects
050210 logistics & transportation ,Materials science ,biology ,05 social sciences ,Analytical chemistry ,Order (ring theory) ,Charge (physics) ,02 engineering and technology ,Type (model theory) ,021001 nanoscience & nanotechnology ,biology.organism_classification ,Bifidobacterium animalis ,Electrical resistivity and conductivity ,Ionization ,0502 economics and business ,Charge carrier ,Surface charge ,0210 nano-technology - Abstract
The influence of relative humidity (RH) on quasistatic current-voltage ${(I-V)}$ characteristics of Bifidobacterium animalis subsp. lactis BB-12 thin layers have been studied for the first time. The value of electrical conductivity in 75$ \%$ RH was found to be in the order of 10$^{-7}$ (ohm cm)$^{-1}$ which was 10$^{6}$ orders of magnitude higher than that observed in dry atmosphere. Here we also demonstrated that RH played a key role in hysteresis behaviour of the measured ${(I-V)}$ characteristics. FTIR measurements showed that under water moisture environment the associated bonds for amine and carboxyl group were greatly strengthened that was the source of number of free charge carries after ionization. The type of surface charge of Bifidobacterium animalis subsp. lactis BB-12 was found to be negative by zeta potential measurements, claiming that electrons were the charge carriers.
- Published
- 2019
5. Ground state properties of charmed hypernuclei within a mean field approach
- Author
-
H. Güven, K. Bozkurt, E. Khan, J. Margueron, Laboratoire de Physique des 2 Infinis Irène Joliot-Curie (IJCLab), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), Institut de Physique des 2 Infinis de Lyon (IP2I Lyon), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université Claude Bernard Lyon 1 (UCBL), and Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Nuclear Theory ,[PHYS.NUCL]Physics [physics]/Nuclear Theory [nucl-th] ,force: difference ,hypernucleus ,FOS: Physical sciences ,[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex] ,01 natural sciences ,Nuclear Theory (nucl-th) ,High Energy Physics - Phenomenology (hep-ph) ,Condensed Matter::Superconductivity ,0103 physical sciences ,ground state ,Nuclear Experiment (nucl-ex) ,010306 general physics ,Nuclear Experiment ,Lambda/c+ ,Hartree-Fock approximation ,010308 nuclear & particles physics ,particle: energy ,High Energy Physics::Phenomenology ,binding energy ,baryon ,High Energy Physics - Phenomenology ,[PHYS.HPHE]Physics [physics]/High Energy Physics - Phenomenology [hep-ph] ,High Energy Physics::Experiment ,Coulomb - Abstract
Closed shell charmed hypernuclei $^5_{\Lambda_c}$Li, $^{17}_{\Lambda_c}$F, $^{41}_{\Lambda_c}$Sc, $^{57}_{\Lambda_c}$Cu, $^{133}_{\Lambda_c}$Sb and $^{209}_{\Lambda_c}$Bi are calculated within Hartree-Fock approach by using three different force sets derived from microscopic Brueckner-Hartree-Fock calculations of $\Lambda$ hypernuclei. Ground state properties (binding energies, $\Lambda_c$ separation energies, $\Lambda_c$ single particle energies and $\Lambda_c$ densities) of charmed nuclei are examined. Due to the Coulomb repulsion between protons and the $\Lambda_c$ baryon, charmed hypernuclei are most bound for $16\leq$A$\leq 41$, where $^{17}_{\Lambda_c}$F can be considered as an excellent candidate to measure charmed hypernuclei. The competition between the attractive nucleon-$\Lambda_c$ interaction and the Coulomb repulsion is discussed, and we compare $\Lambda$ and $\Lambda_c$ hypernuclei properties., Comment: 9 pages, 6 figures
- Published
- 2021
6. A rare developmental anomaly associated with right colon cancer: appendix vermiformis agenesis
- Author
-
Mustafa, Gok, Erdogan, Sozuer, Ugur, Topal, Muhammet, Akyuz, Gamze K, Bozkurt, Merve, Hamurcu, and Kemal, Deniz
- Subjects
Incidental Findings ,Colonic Neoplasms ,Humans ,Female ,Appendix ,Aged ,Congenital Abnormalities - Abstract
Appendix vermiformis agenesis is quite rare. It is seen in 1/100,000 of patients who underwent laparotomy with an initial diagnosis of appendicitis. A 72-year-old woman who had not undergone any previous surgery was operated on for mechanical intestinal obstruction. Right hemicolectomy was performed due to obstructive tumoral mass in the hepatic flexure. There was no appendix vermiformis in exploration. Before deciding on the diagnosis of appendix agenesis, a thorough and rigorous exploration should be performed in ileocecal region and ascending colon. In our case, the diagnosis of appendix agenesis was incidental. However, it should be kept in mind that appendix agenesis may be present in patients undergoing surgery with the diagnosis of acute appendicitis. KEY WORDS: Appendicular agenesis, Colorectal carsinoma, Congenital Abnormalities.La agenesia dell’appendice vermiforme è abbastanza rara, e si riscontra in 1 su 100.000 pazienti sottoposti a laparotomia con una diagnosi iniziale di appendicite. Una donna di 72 anni che non aveva subito alcun intervento chirurgico precedente è stata operata per ostruzione intestinale meccanica. L’emicolectomia destra è stata eseguita a causa della presenza di una massa tumorale ostruttiva a livello della flessura epatica. All’esplorazione del pezzo operatorio non si è trovata l’appendice vermiforme. Prima di concludere per una diagnosi di agenesia dell’appendice, deve essere eseguita un’esplorazione approfondita e rigorosa nella regione ileocecale e nel colon ascendente. Nel nostro caso, la diagnosi di agenesia dell’appendice è stata casuale.Tuttavia, va tenuto presente che l’agenesia dell’appendice può essere presente in pazienti sottoposti a chirurgia con diagnosi di appendicite acuta.
- Published
- 2020
7. Surgical versus Transcatheter Aortic Valve Replacement for Treatment of Bicuspid Aortic Valve Stenosis
- Author
-
H. Langer, K. Bozkurt, S. Ensminger, A. Aboud, E. Emmel, B. Fujita, M. Saad, I. Eitel, and T. Kurz
- Subjects
medicine.medical_specialty ,Stenosis ,Bicuspid aortic valve ,Valve replacement ,Transcatheter aortic ,business.industry ,medicine.medical_treatment ,Internal medicine ,medicine ,Cardiology ,medicine.disease ,business - Published
- 2020
8. Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries
- Author
-
De Backer, Guy Jankowski, Piotr Kotseva, Kornelia and Mirrakhimov, Erkin Reiner, Zeljko Ryden, Lars Tokgozoglu, Lale Wood, David De Bacquer, Dirk Abreu, A. Aguiar, C. and Badariene, J. Bruthans, J. Castro Conde, A. Cifkova, R. and Crowley, J. Davletov, K. De Smedt, D. De Sutter, J. and Deckers, J. W. Dilic, M. Dolzhenko, M. Druais, H. and Dzerve, V. Erglis, A. Fras, Z. Gaita, D. Gotcheva, N. and Grobbee, D. E. Gyberg, V. Ali, H. Hasan Heuschmann, P. and Hoes, A. W. Lalic, N. Lehto, S. Lovic, D. Maggioni, A. P. Mancas, S. Marques-Vidal, P. Mellbin, L. Milicic, D. Oganov, R. Pogosova, N. Stagmo, M. Stoerk, S. and Sundvall, J. Tsioufis, K. Vulic, D. Wood, D. A. and Jennings, C. Adamska, A. Adamska, S. Mellbin, L. and Tuomilehto, J. Schnell, O. Fiorucci, E. Glemot, M. and Larras, F. Missiamenou, V. Maggioni, A. Taylor, C. and Ferreira, T. Lemaitre, K. Raman, L. Sundvall, J. and DeSmedt, D. De Sutter, J. Willems, A. M. De Pauw, M. and Vervaet, P. Bollen, J. Dekimpe, E. Mommen, N. Van Genechten, G. Dendale, P. Bouvier, C. A. Chenu, P. and Huyberechts, D. Persu, A. Dilic, M. Begic, A. Nalbantic, A. Durak Dzubur, A. Hadzibegic, N. Iglica, A. Kapidjic, S. Bico, A. Osmanagic Resic, N. Bajramovic, N. Sabanovic and Zvizdic, F. Vulic, D. Kovacevic-Preradovic, T. and Popovic-Pejicic, S. Djekic, D. Gnjatic, T. Knezevic, T. and Kovacevic-Preradovic, T. Kos, Lj Popovic-Pejicic, S. and Stanetic, B. Topic, G. Gotcheva, N. Georgiev, Borislav and Terziev, A. Vladimirov, G. Angelov, A. Kanazirev, B. and Nikolaeva, S. Tonkova, D. Vetkova, M. Milicic, D. and Bosnic, A. Dubravcic, M. Glavina, M. Mance, M. and Pavasovic, S. Samardzic, J. Batinic, T. Crljenko, K. and Delic-Brkljacic, D. Dula, K. Golubic, K. Klobucar, I. and Kordic, K. Kos, N. Nedic, M. Olujic, D. Sedinic, V. and Blazevic, T. Pasalic, A. Percic, M. Sikic, J. Bruthans, J. Cifkova, R. Hasplova, K. Sulc, P. Wohlfahrt, P. and Mayer, Jr., O. Cvicela, M. Filipovsky, J. Gelzinsky, J. and Hronova, M. Hasan-Ali, H. Bakery, S. Mosad, E. Hamed, H. B. Ibrahim, A. Elsharef, M. A. Kholef, E. F. Shehata, A. and Youssef, M. Elhefny, E. Farid, H. Moustafa, T. M. and Sobieh, M. S. Kabil, H. Abdelmordy, A. Lehto, S. and Kiljander, E. Kiljander, P. Koukkunen, H. Mustonen, J. and Cremer, C. Frantz, S. Haupt, A. Hofmann, U. Ludwig, K. and Melnyk, H. Noutsias, M. Karmann, W. Prondzinsky, R. and Herdeg, C. Hoevelborn, T. Daaboul, A. Geisler, T. and Keller, T. Sauerbrunn, D. Walz-Ayed, M. Ertl, G. Leyh, R. Stoerk, S. Heuschmann, P. Ehlert, T. Klocke, B. and Krapp, J. Ludwig, T. Kaes, J. Starke, C. Ungethuem, K. and Wagner, M. Wiedmann, S. Tsioufis, K. Tolis, P. and Vogiatzi, G. Sanidas, E. Tsakalis, K. Kanakakis, J. and Koutsoukis, A. Vasileiadis, K. Zarifis, J. Karvounis, C. and Crowley, J. Gibson, I. Houlihan, A. Kelly, C. O'Donnell, M. Bennati, M. Cosmi, F. Mariottoni, B. Morganti, M. and Cherubini, A. Di Lenarda, A. Radini, D. Ramani, F. and Francese, M. G. Gulizia, M. M. Pericone, D. Davletov, K. and Aigerim, K. Bekbolat, Z. Amirov, B. Assembekov, B. and Chernokurova, E. Ibragimova, F. Kodasbayev, A. Markova, A. and Asanbaev, A. Toktomamatov, U. Tursunbaev, M. Zakirov, U. and Abilova, S. Arapova, R. Bektasheva, E. Esenbekova, J. and Neronova, K. Asanbaev, A. Baigaziev, K. Toktomamatov, U. and Zakirov, U. Baitova, G. Zheenbekov, T. Erglis, A. and Andrejeva, T. Bajare, I. Kucika, G. Labuce, A. Putane, L. Stabulniece, M. Dzerve, V. Klavins, E. Sime, I. and Badariene, J. Gedvilaite, L. Peciuraite, D. Sileikiene, V. and Skiauteryte, E. Solovjova, S. Sidabraite, R. Briedis, K. and Ceponiene, I. Jurenas, M. Kersulis, J. Martinkute, G. and Vaitiekiene, A. Vasiljevaite, K. Veisaite, R. Plisiene, J. Siurkaite, V. Vaiciulis, Z. Czarnecka, D. Koziel, P. and Podolec, P. Nessler, J. Gomula, P. Mirek-Bryniarska, E. and Bogacki, P. Wisniewski, A. Pajak, A. Wolfshaut-Wolak, R. and Bucko, J. Kaminski, K. Lapinska, M. Paniczko, M. and Raczkowski, A. Sawicka, E. Stachurska, Z. Szpakowicz, M. and Musial, W. Dobrzycki, S. Bychowski, J. Kosior, D. A. and Krzykwa, A. Setny, M. Kosior, D. A. Rak, A. Gasior, Z. and Haberka, M. Gasior, Z. Haberka, M. Szostak-Janiak, K. and Finik, M. Liszka, J. Botelho, A. Cachulo, M. Sousa, J. Pais, A. Aguiar, C. Durazzo, A. Matos, D. and Gouveia, R. Rodrigues, G. Strong, C. Guerreiro, R. and Aguiar, J. Abreu, A. Cruz, M. Daniel, P. Morais, L. and Moreira, R. Rosa, S. Rodrigues, I. Selas, M. Gaita, D. and Mancas, S. Apostu, A. Cosor, O. Gaita, L. Giurgiu, L. Hudrea, C. Maximov, D. Moldovan, B. Mosteoru, S. and Pleava, R. Ionescu, M. Parepa, I. Pogosova, N. and Arutyunov, A. Ausheva, A. Isakova, S. Karpova, A. and Salbieva, A. Sokolova, O. Vasilevsky, A. Pozdnyakov, Y. and Antropova, O. Borisova, L. Osipova, I. Lovic, D. and Aleksic, M. Crnokrak, B. Djokic, J. Hinic, S. Vukasin, T. Zdravkovic, M. Lalic, N. M. Jotic, A. Lalic, K. and Lukic, L. Milicic, T. Macesic, M. Gajovic, J. Stanarcic and Stoiljkovic, M. Djordjevic, D. Kostic, S. Tasic, I. and Vukovic, A. Fras, Z. Jug, B. Juhant, A. Krt, A. and Kugonjic, U. Chipayo Gonzales, D. Gomez Barrado, J. J. and Kounka, Z. Marcos Gomez, G. Mogollon Jimenez, M. V. Ortiz Cortes, C. Perez Espejo, P. Porras Ramos, Y. Colman, R. and Delgado, J. Otero, E. Perez, A. Fernandez-Olmo, M. R. and Torres-LLergo, J. Vasco, C. Barrenada, E. Botas, J. and Campuzano, R. Gonzalez, Y. Rodrigo, M. de Pablo, C. and Velasco, E. Hernandez, S. Lozano, C. Gonzalez, P. and Castro, A. Dalmau, R. Hernandez, D. Irazusta, F. J. and Velez, A. Vindel, C. Gomez-Doblas, J. J. Garcia Ruiz, V. and Gomez, L. Gomez Garcia, M. Jimenez-Navarro, M. Molina Ramos, A. Marzal, D. Martinez, G. Lavado, R. Vidal, A. and Bostrom-Nilsson, V. Kjellstrom, B. Shahim, B. Smetana, S. and Hansen, O. Stensgaard-Nake, E. Deckers, J. W. Klijn, A. J. Mangus, T. J. P. Peters, R. J. G. Reimer, W. Scholte Op and Snaterse, M. Aydogdu, S. Erol, C. Oturk, S. Kaya, C. Tulunay Ahmetoglu, Y. Ergene, O. Akdeniz, B. Cirgamis, D. Kultursay, S. Akkoyun H. Kayikcioglu, M. Catakoglu, A. B. and Cengel, A. Kocak, A. A. Agirbasli, M. A. Aciksari, G. and Cekin, M. E. Kaya, E. B. Kocyigit, D. Ongen, Z. and Ozmen, E. Sansoy, V. Kaya, A. Oktay, V. Temizhan, A. and Unal, S. Yakut, I. Kalkan, A. K. Bozkurt, E. Kasapkara, H. A. Dolzhenko, M. Faradzh, C. Hrubyak, L. Konoplianyk, L. Kozhuharyova, N. Lobach, L. Nesukai, V. Nudchenko, O. and Simagina, T. Yakovenko, L. Azarenko, V. Potabashny, V. and Bazylevych, A. Bazylevych, M. Kaminska, K. Panchenko, L. and Shershnyova, O. Ovrakh, T. Serik, S. Kolesnik, T. and Kosova, H. Adamska, A. Adamska, S. Jennings, C. Atkin, A. Hoye P. Fellowes, D. Lindsay, S. Atkinson, C. and Kranilla, C. Vinod, M. Beerachee, Y. Bennett, C. Broome, M. Bwalya, A. Caygill, Lindsay Dinning, L. Gillespie, A. and Goodfellow, R. Guy, J. Idress, T. Mills, C. Morgan, C. Oustance, N. Singh, N. Yare, M. Jagoda, J. M. and Bowyer, H. Christenssen, V. Groves, A. Jan, A. Riaz, A. and Gill, M. Sewell, T. A. Gorog, D. Baker, M. De Sousa, P. Mazenenga, T. Porter, J. Haines, F. Peachey, T. and Taaffe, J. Wells, K. Ripley, D. P. Forward, H. McKie, H. and Pick, S. L. Thomas, H. E. Batin, P. D. Exley, D. and Rank, T. Wright, J. Kardos, A. Sutherland, S. -B. Wren, L. Leeson, P. Barker, D. Moreby, B. Sawyer, J. and Stirrup, J. Brunton, M. Brodison, A. Craig, J. Peters, S. Kaprielian, R. Bucaj, A. Mahay, K. Oblak, M. and Gale, C. Pye, M. McGill, Y. Redfearn, H. Fearnley, M. and EUROASPIRE V Collaborators Writing Comm Sci Steering Executive Comm Coordinating Ctr Diabet Ctr Data Management Ctr Stat Anal Ctr Cent Lab Study Ctr Org Investigators Other
- Abstract
Background and aims: One of the objectives of the ESC-EORP EUROASPIRE V survey is to determine how well European guidelines on the management of dyslipidaemias are implemented in coronary patients. Methods: Standardized methods were used by trained technicians to collect information on 7824 patients from 130 centers in 27 countries, from the medical records and at a visit at least 6 months after hospitalization for a coronary event. All lipid measurements were performed in one central laboratory. Patients were divided into three groups: on high-intensity LDL-C-lowering-drug therapy (LLT), on low or moderate-intensity LLT and on no LLT. Results: At the time of the visit, almost half of the patients were on a high-intensity LLT. Between hospital discharge and the visit, LLT had been reduced in intensity or interrupted in 20.8% of the patients and had been started or increased in intensity in 11.7%. In those who had interrupted LLT or had reduced the intensity, intolerance to LLT and the advice of their physician were reported as the reason why in 15.8 and 36.8% of the cases, respectively. LDL-C control was better in those on a high-intensity LLT compared to those on low or moderate intensity LLT. LDL-C control was better in men than women and in patients with self-reported diabetes. Conclusions: The results of the EUROASPIRE V survey show that most coronary patients have a less than optimal management of LDL-C. More professional strategies are needed, aiming at lifestyle changes and LLT adapted to the need of the individual patient.
- Published
- 2019
9. Surgical staging of low-risk Stage IA endometrioid endometrial cancers
- Author
-
E, Erdemoglu, Y, Yalcin, and K K, Bozkurt
- Subjects
Humans ,Lymph Node Excision ,Female ,Neoplasm Invasiveness ,Middle Aged ,Carcinoma, Endometrioid ,Aged ,Endometrial Neoplasms ,Neoplasm Staging ,Retrospective Studies - Abstract
Surgical staging in early endometrial cancer is not universally done and lymphadenectomy in early-stage disease is controversial. Aim of the present study was to evaluate surgical staging in patients with endometrioid histology, FIGO Stage IA endometrial cancer.Eighty-seven patients with FIGO Stage IA, low-risk patients were included in the study. Staging surgery group included patients who had comprehensive surgical staging (hysterectomy, oophorectomy, and pelvic lymph node dissection with or without para-aortic lymph node dissection). Non-staging surgery group included patients who had hysterectomy, and bilateral oophorectomy with or without lymph node sampling. Two groups were compared for lymph node status, occult cervical involvement, other prognostic factors, and outcome were analyzed.In total 17.2% of patients were upstaged in final pathological examination; 12.9% in non-staging surgery group and 24.2% in staging surgery group. Upstaging was due to lymph node involvement (6%), cervical stromal invasion (13.7%), and myometrial invasion greater than 50% (1.1%). Median pelvic lymph node number was 23 and pelvic lymph node metastases was found in 3% of the patients. Median para-aortic lymph node number was 11.5 and there was one isolated para-aortic lymph node metastases (5.8%).Of the patients, 17.2% had stage migration. Until the issue is solved by future studies, surgical staging might be considered standard surgery for endometrial cancer.
- Published
- 2018
10. Late effects of cutaneous 3-methylcholanthrene exposure on DNA damage-related pleiotropic growth factors and oxidative stress markers in mice.
- Author
-
T., Devrim, H., Ekici, A. K., Devrim, M., Sozmen, A., Senol, K. K., Bozkurt, O., Duru, and S., Yalcin
- Subjects
DNA damage ,MULTIDRUG resistance ,OXIDATIVE stress ,LABORATORY mice ,CYTOKINES - Abstract
BACKGROUND: Skin is the body's fi rst defence against direct exposure to variety of chemicals. Polycyclic aromatic hydrocarbons such as 3-methylcholanthrene (3-MC) are common in polluted urban air and have a potential of producing harmful effects. Moreover, their late effects can occur months or years after exposure. OBJECTIVES: We aimed to investigate the long-term effects of 3-MC induced dermal toxicity on the expression of markers of apoptosis, pleiotropic cytokines, and oxidative stress and to determine the protective effect of cisplatin. METHODS: Groups were designed as control (group 1), 3-MC applied (group 2) and 3-MC+cisplatin applied mice (group 3). Cutaneous expressions of TGFß, PDGFA, PDGFC, bFGF, PDGFRa, USP28, and Ki67 were evaluated with qPCR. Total oxidant (TOS), total antioxidant (TAS) and oxidative stress index (OSI) values were determined in liver and kidney tissues. RESULTS: The expression levels of TGFß, PDGFRa, USP-28, Ki67, and PDGFA were decreased significantly in MC applied groups. Renal TAS levels were significantly lower in group-3. Liver and kidney OSI values were increased in both groups 2 and 3. CONCLUSION: The results indicated that low dose 3-MC caused oxidative stress and downregulated apoptotic and cytokine markers in the long term and cisplatin had no ameliorative effects on this degeneration processes (Tab. 3, Fig. 3, Ref. 32). Text in PDF www.elis.sk. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
11. A Rare Co-incidental Presentation: Multiple Myeloma and Pleural Adenocarcinoma: A Case Report
- Author
-
Murat Albayrak, Ozlem Sahin Balcik, Yucel Tekin, Mehmet Ersaydi, Süleyman Sırrı Gökalp, Hatice K. Bozkurt, Osman Yokuş, and Mustafa Akar
- Subjects
Thorax ,Melphalan ,medicine.medical_specialty ,Pleural effusion ,business.industry ,Hematology ,respiratory system ,medicine.disease ,respiratory tract diseases ,Surgery ,Oncology ,hemic and lymphatic diseases ,medicine ,Adenocarcinoma ,Presentation (obstetrics) ,Respiratory system ,business ,Pathological ,Multiple myeloma ,medicine.drug - Abstract
In this case report we overview the diagnostic and therapeutic approaches for pleural effusions encountered during the tre- atment and follow-up of patients with myeloma in the light of the current medical literature. A 73-year-old female patient with a stage IIIA multiple myeloma was being treated with melphalan and methyl prednisolone. In the third month of the treat- ment, she had complaints of coughing, dyspnea and right side pain. Computed tomographic examination of the thorax re- vealed pleural effusion. Pathological examinations of the pleural fluid and pleural biopsy specimen were compatible with ade- nocarcinoma. Repeated examinations did not reveal a progression in myeloma or a pleural involvement of myeloma. The pa- tient died of respiratory insufficiency due to the progression of the pleural adenocarcinoma.
- Published
- 2011
12. POSTER VIEWING SESSION - ENDOMETRIOSIS, ENDOMETRIUM, IMPLANTATION AND FALLOPIAN TUBE
- Author
-
K. K. Palial, J. Drury, L. Heathcote, A. Valentijin, R. G. Farquharson, R. Gazvani, P. S. Rudland, D. K. Hapangama, N. Celik, O. Celik, E. Aktan, E. Ozerol, E. Celik, K. Bozkurt, H. Paran, S. Hascalik, I. Ozerol, T. Arase, T. Maruyama, H. Uchida, K. Miyazaki, H. Oda, S. Uchida-Nishikawa, M. Kagami, A. Yamazaki, K. Tamaki, Y. Yoshimura, M. De Vos, C. Ortega, J. Smitz, I. Van Vaerenbergh, C. Bourgain, P. Devroey, D. Luciano, C. Exacoustos, E. Zupi, A. A. Luciano, D. Arduini, W. A. Palomino, F. Argandona, P. Kohen, R. Azua, A. Scarella, L. Devoto, B. McKinnon, N. A. Bersinger, M. D. Mueller, M. Bonavita, M. Mattila, F. P. Ferreira, V. Maia-Filho, A. M. Rocha, P. Serafini, E. L. A. Motta, H. Kim, C. H. Kim, R. M. You, H. Y. Nah, J. W. Lee, H. J. Kang, B. M. Kang, H. Letur - Koenirsch, D. Haouzi, F. Olivennes, C. Rouleau, P. Cohen-Bacri, H. Dechaud, S. Hamamah, T. D'Hooghe, L. Hummelshoj, G. A. J. Dunselman, C. D. Dirksen, W. E. R. F. EndoCost Consortium, S. Simoens, R. Novembri, S. Luisi, P. Carrarelli, A. L. L. Rocha, P. Toti, F. M. Reis, P. Florio, F. Petraglia, K. D. Bruce, K. H. Sadek, N. Macklon, F. R. Cagampang, Y. Cheong, M. Goudakou, A. Kalogeraki, I. Matalliotakis, A. Papatheodorou, T. Pasadaki, A. Karkanaki, I. Prapas, I. Panagiotidis, E. Kasapi, D. Barlow, J. Oliver, E. Loumaye, M. Khanmohammadi, S. kazemnejad, S. darzi, S. Khanjani, A. Zarnani, M. Akhondi, C. W. Tan, C. P. Ng, S. F. Loh, H. H. Tan, M. Choolani, L. Griffith, J. Chan, K. L. Andersson, J. Sundqvist, G. Scarselli, K. Gemzell-Danielsson, P. G. Lalitkumar, S. Jana, R. Chattopadhyay, C. Datta Ray, K. Chaudhury, B. N. Chakravarty, N. Hannan, J. Evans, C. Hincks, L. J. F. Rombauts, L. A. Salamonsen, D. Choi, J. Lee, J. Park, H. Chang, M. Kim, K. Hwang, K. Takeuchi, T. Kurematsu, Y. Fukumoto, Y. Yuki, Y. Kuroki, Y. Homan, Y. Sata, M. Takeuchi, E. Munoz Munoz, G. Ortiz Olivera, I. Fernandez Lopez, B. Martinez Martinez, J. Aguilar Prieto, S. Portela Perez, A. Pellicer Martinez, M. Keltz, M. Sauerbrun, A. Breborowicz, E. Gonzales, S. Vicente-Munoz, L. Puchades-Carrasco, I. Morcillo, J. J. Hidalgo, J. Gilabert-Estelles, E. Novella-Maestre, A. Pellicer, A. Pineda-Lucena, K. A. Yavorovskaya, T. A. Okhtyrskaya, T. A. Demura, N. M. Faizulina, L. S. Ezhova, E. A. Kogan, J. P. Bilibio, C. A. B. Souza, G. P. Rodini, V. Genro, C. G. Andreoli, E. de Conto, J. S. L. Cunha-Filho, M. Saare, D. Soritsa, L. Jarva, K. Vaidla, P. Palta, M. Laan, H. Karro, A. Soritsa, A. Salumets, M. Peters, A. Miskova, M. Pilmane, D. Rezeberga, S. Assou, H. Letur, P. Piomboni, A. Stendardi, L. Gambera, V. De Leo, R. Focarelli, K. Tamm, J. Simm, M. Metsis, A. Vodolazkaia, A. Fassbender, C. M. Kyama, A. Bokor, D. Schols, D. Huskens, C. Meuleman, K. Peeraer, C. Tomassetti, T. M. D'Hooghe, K. Machens, W. Afhuppe, A. Schulz, K. Diefenbach, B. Schutt, T. Faustmann, J. Reischl, S. Altmae, J. Reimand, T. Laisk, O. Hovatta, R. Kolde, J. Vilo, A. Stavreus-Evers, J. H. Lee, S. G. Kim, Y. Y. Kim, I. H. Park, H. G. Sun, K. H. Lee, K. Ezoe, H. Kawano, A. Yabuuchi, K. Ochiai, H. Nagashima, H. Osada, N. Kagawa, O. Kato, I. Tamura, H. Asada, T. Taketani, H. Tamura, N. Sugino, J. Garcia Velasco, L. Prieto, J. F. Quesada, O. Cambero, M. Toribio, C. Y. Hur, K. S. Lim, W. D. Lee, J. H. Lim, A. Germeyer, L. Nelson, A. Graham, J. Jauckus, T. Strowitzki, B. Lessey, I. Gyulmamedova, O. Illina, I. Illin, I. Mogilevkina, A. Chaika, O. Nosenko, I. Boykova, E. Gulmamedova, H. Isik, O. Moraloglu, A. L. I. Seven, S. Kilic, U. Erkayiran, M. Caydere, S. Batioglu, M. Alhalabi, S. Samawi, A. Taha, N. Kafri, S. Modi, A. Khatib, J. Sharif, A. Othman, S. Lancuba, C. Branzini, M. Lopez, A. Baricalla, C. Cristina, J. Chen, Y. Jiang, X. Zhen, Y. Hu, G. Yan, H. Sun, J. Mizumoto, J. Ueno, F. M. Carvalho, G. Casals, J. Ordi, M. Guimera, M. Creus, F. Fabregues, R. Casamitjana, F. Carmona, J. Balasch, Y. S. Choi, K. C. Kim, K. H. Kim, B. S. Lee, S. H. Kim, L. Overbergh, E. Verdrengh, C. Kyama, E. Waelkens, C. Mathieu, T. Iwasa, K. Hatano, E. Hasegawa, H. Ito, K. Isaka, F. Reis, K. S. Lee, J. K. Joo, J. B. Son, J. R. Choi, A. Vidali, D. H. Barad, N. Gleicher, M. Sayyah-Melli, and M. Kazemi-Shishvan
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Obstetrics ,Rehabilitation ,Endometriosis ,Obstetrics and Gynecology ,Endometrium ,medicine.disease ,medicine.anatomical_structure ,Reproductive Medicine ,medicine ,Session (computer science) ,business ,Fallopian tube - Published
- 2011
13. Giant Cornu Cutaneum Superimposed on Basal Cell Carcinoma
- Author
-
HN Azakli, AT Mansur, A Babacan, K Bozkurt, S Agirgol, and A Dikmen
- Subjects
Pathology ,medicine.medical_specialty ,Seborrhoeic keratosis ,business.industry ,Case Report ,General Medicine ,medicine.disease ,Lesion ,Female patient ,medicine ,Basal cell ,Basal cell carcinoma ,Surgical excision ,medicine.symptom ,business - Abstract
Cornu cutaneum (CC) is a clinical term that describes the horn-like keratotic lesions extending vertically from the skin. Benign, premalignant or malignant lesions may be present at the base of CC. Seborrhoeic keratosis and squamous cell carcinoma (SCC) are the most commonly reported benign and malignant forms, respectively. Basal cell carcinoma (BCC) at the base is rare. Here, we report on an 85-year old female patient having multiple CC lesions, one being giant on her face and two of the lesions diagnosed with BCC at the base. This case is of significance due to the presence of giant and multiple CC and detection of BCC at the base of more than one lesion. This present case indicates the need for the treatment of possible malignant lesions underlying CC in the elderly by total surgical excision.
- Published
- 2015
14. Maternal fetal medicine-perinatology
- Author
-
C. Tekcan, M. M. Naki, N. Özcan, M. Cebi, F. Kanadikirik, R. Has, M. Aydoadu, J. P. Frenz, W. Schröder, F. S. Dede, E. E. Kovalak, O. Gelisen, H. Dede, B. Sariisik, A. Haberal, E. Caliskan, E. Turkoz, A. Corakci, S. Ozeren, I. Yucesoy, N. Terzioglu, W. Köhler, A. Feige, J. Atad, R. Auslender, M. Bardicef, I. Calderon, E. Leron, H. Abramovici, I. F. Ertas, S. Kahyaoglu, M. Turgay, N. Sut, B. Yilmaz, M. Ozel, N. Danisman, I. Kocak, C. Üstün, E. Bese, M. Ingec, B. Borekci, M. Yilmaz, S. Kadanali, F. Erdogan, Y. Kumtepe, I. I. Gümüs, N. O. Turhan, E. Tamburaci, O. Gunduz, M. Akar, M. Simsek, G. Zorlu, O. Balci, K. Gezginc, A. Acar, C. Akyürek, A. Biri, I. Guler, O. Himmetoglu, M. Y. Karaoguz, Sevim Balci, H. A. Tanriverdi, D. Usal, E. Cinar, A. Barut, B. Pilanci, A. Imren, D. Öztekin, S. Kurt, S. Tinar, N. Canoruc, A. Kale, E. Kale, A. Yalinkaya, N. Akdeniz, M. Gol, B. Tuna, S. Guclu, S. Altunyurt, N. Demir, B. Ciftci, E. Senol, S. Haznedarohlu, K. Gucuyener, R. Gursoy, I. Turgay, M. Gocmen, R. Neslihanoglu, M. K. Kokanali, C. Kunt, E. G. Yapar, S. Taskin, A. Yarci, E. A. Bozaci, C. Atabekoglu, F. Söylemez, M. Seval, B. Özmen, S. Mammadova, C. Unlü, D. Güleryüz, Ö. Sahincioglu, N. Öztürk, S. Yalvac, A. Erten, I. Dölen, A. Gul, A. Cebeci, A. Gedikbasi, O. Erol, Y. Ceylan, A. I. Tekirdag, M. A. Onan, A. Turp, M. Kurdoglu, G. Gunaydin, Z. Kurdoglu, A. Erdem, O. Tulumbaci, S. Turkoglu, B. Boyaci, M. B. Tiras, O. Kadayifci, S. C. Demir, I. F. Ürünsak, T. Özgünen, I. C. Evrüke, A. B. Güzel, I. F. Urünsak, A. Uckuyu, E. E. Ozcimen, O. Nisanoglu, F. Yanik, S. Akgun, E. Kuscu, N. C. Sayin, M. T. Canda, N. Ahmet, I. Kurt, F. G. Varol, S. Erkanli, K. Caliskan, T. Bagis, E. Kilicdag, E. Tarim, L. Tutuncu, N. Ardic, E. Mungen, A. R. Ergur, Y. Z. Yergok, N. Cölcimen, H. G. Sahin, M. Kamaci, I. Bezircioglu, M. Bicer, D. Uysal, S. Yigit, A. Baloglu, L. Karci, F. Ozder, A. Yüksel, S. Büyükkurt, B. Tatli, I. Kalelioglu, M. D. Kesim, Y. Aydin, A. Atis, A. Gezer, S. Erkan, Y. Simsek, N. Kahraman, S. Uludag, T. Altinok, M. Erdemoglu, Y. Ozcan, G. Köse, T. Tuncel, N. Aka, P. Kumru, M. A. Güven, P. Ciragil, E. Ozdemir, E. Aktan, K. Bozkurt, M. Kilinc, H. Ekerbicer, S. Ceylaner, G. Ceylaner, D. Gul, E. Ertas, C. Batukan, A. Ozbek, G. Demirpolat, M. Uzel, A. Basaran, G. Bozdag, S. Dagdelen, A. Gürlek, S. Beksac, Özkan A. Arici, T. Isparta, F. C. Dikis, S. B. Civas, C. Ispahi, I. K. Kalelioalu, E. Gilbaz, L. Ibrahimoglu, H. Ermis, A. Yildirim, B. Dane, M. Yayla, C. Dane, M. Özek, I. K. Kalelioglu, Dane Cem, Dural Salih, A. Cetin, M. Kiray, E. Ataoglu, Y. Döventas, H. Delier, A. Yildiz, A. Köksal, N. Celik, H. Yetimalar, A. Keklik, H. Ivit, K. Cukurova, D. Hizli, S. Dilbaz, N. Acer, S. Deveci, B. Dilbaz, S. Yilmaz, Bulbul M. Bicer, E. Karakaya, M. Pehlivan, E. Doger, C. Duman, G. Turker, Y. Cakiroglu, S. Ozkan, D. Dundar, S. Caliskan, V. Aksakalli, G. Önal, B. Ö. Demirkaya, M. Yavuz, T. Bozkurt, O. Ozyuncu, M. C. Salman, T. Durukan, L. Onderoglu, O. Deren, A. Ayhan, C. Tufekci, H. Karalök, E. Ilter, L. Cil, A. E. Karalök, H. Akyol, Ö. Oruc, M. Ekin, M. Ülku, P. Caglar, C. Demirel, T. Güngör, L. Mollamahmutoglu, T. Usta, B. Özdemir, U. Ates, N. Numanoglu, A. Seyhan, B. Sidal, B. Ozdemir, S. Ortakuz, A. Öztarhan, O. Dogan, S. Ilbaz, A. Tarcan, A. Sivaslioglu, V. Akbulut, H. Sade, A. Dede, M. Özel, S. Günaydin, U. Atmaca, B. Ata, S. Akar, B. Vural, S. Özkan, P. Costur, H. Dalcik, S. Filiz, I. Yücesoy, E. Erdemoglu, A. Kolusari, A. V. Sahin, A. Tas, C. Dalcik, G. Yücesoy, E. Unlubilgin, B. Demir, M. Sonmezer, M. Erdem, S. Gezer, Ü. Bayar, F. Demir, O. Api, E. Aygün, B. Kars, B. Cengizoglu, S. Bulut, C. Turan, O. Unal, O. Ünal, Y. K. Karageyim, O. Balcik, Ö. Kara, U. Dogance, A. Akil, M. Api, D. Balsak, M. E. Avci, B. Elveren, M. Hanhan, K. Kayhan, B. Özdal, S. Cavkaytar, M. Özat, O. Aksakal, E. Ozdas, T. Filiz, E. Asian, B. Haydardedeoglu, E. Simsek, F. Bolat, S. Ocak, S. Zeteroglu, A. Deveci, A. Gungoren, E. Borazan, A. Hakverdi, and A. Andi
- Subjects
medicine.medical_specialty ,business.industry ,Obstetrics ,Obstetrics and Gynecology ,Medicine ,General Medicine ,business ,Human genetics ,Maternal-fetal medicine - Published
- 2005
15. Granulosa cell tumor and concurrent endometrial cancer with (18)F-FDG uptake
- Author
-
Ilker, Günyeli, Kemal K, Bozkurt, Yakup, Yalçın, Burak, Tatar, Sevim S, Cerçi, and Evrim, Erdemoğlu
- Subjects
Adult ,Fluorodeoxyglucose F18 ,Positron-Emission Tomography ,Humans ,Biological Transport ,Female ,Tomography, X-Ray Computed ,Endometrial Neoplasms ,Granulosa Cell Tumor - Abstract
The findings and the role of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) for the diagnosis of ovarian granulosa cell tumor (OG) are described. We present the pre-operative findings of (18)F-FDG PET/CT scan of a case of OG concurrent with endometrium cancer and endometrial hyperplasia, which revealed a 48mm mass demonstrating mild increased metabolic activity on the right ovary. Total abdominal hysterectomy and bilateral salpingo-oophorectomy was performed. Frozen and paraffin-enbeded sections showed an encapsulated OG. There were few mitoses. There was concurrent atypical endometrial hyperplasia. In conclusion, we reported a case of an encapsulated OG, which showed mild uptake of the (18)F-FDG with concurrent endometrial cancer. There has been only one report of (18)F-FDG findings in primary ovarian granulosa cell tumor, similar to ours.
- Published
- 2014
16. The cost-of-disease of thromboembolic and hemorrhagic complications associated with atrial fibrillation and its treatment in Turkey: An expert panel approach for estimation of costs
- Author
-
Hakan Kültürsay, M.O. Ozel, Birsen Ince, K. Bozkurt, F. Sumer, E. Tuna, E. Parali, Zeki Öngen, Z.S. Yilmaz, C. Deger, B. Marmarali, G. Ongen, Muzaffer Demir, Oktay Özdemir, and Ege Üniversitesi
- Subjects
Estimation ,medicine.medical_specialty ,business.industry ,Hemorrhagic complication ,Health Policy ,Public Health, Environmental and Occupational Health ,Medicine ,Atrial fibrillation ,Disease ,business ,Intensive care medicine ,medicine.disease - Abstract
WOS: 000318916402418
- Published
- 2013
- Full Text
- View/download PDF
17. The cost-of-disease of deep venous thrombosis and its short- and long-term clinical consequences in turkey: An expert panel approach for estimation of costs
- Author
-
M.O. Ozel, Oktay Özdemir, Z.S. Yilmaz, K. Bozkurt, E. Tuna, E. Parali, Zeki Öngen, G. Ongen, C. Deger, Hakan Kültürsay, B. Marmarali, Muzaffer Demir, F. Sumer, Birsen Ince, and Ege Üniversitesi
- Subjects
Estimation ,medicine.medical_specialty ,Venous thrombosis ,business.industry ,Health Policy ,medicine ,Public Health, Environmental and Occupational Health ,Disease ,Intensive care medicine ,medicine.disease ,business ,Term (time) - Abstract
WOS: 000318916402421
- Published
- 2013
- Full Text
- View/download PDF
18. THE COST-EFFECTIVENESS OF RIVAROXABAN COMPARED TO ENOXAPARIN PLUS ADJUSTED-DOSE WARFARIN FOR THE TREATMENT OF DEEP VENOUS THROMBOSIS (DVT) IN TURKEY
- Author
-
Birsen Ince, G. Ongen, M.O. Ozel, Zeki Öngen, Muzaffer Demir, C. Deger, E. Parali, B. Marmarali, F. Sumer, Z.S. Yilmaz, Hakan Kültürsay, K. Bozkurt, E. Tuna, Oktay Özdemir, and Ege Üniversitesi
- Subjects
Venous thrombosis ,Rivaroxaban ,business.industry ,Cost effectiveness ,Health Policy ,Anesthesia ,Public Health, Environmental and Occupational Health ,medicine ,Dose warfarin ,medicine.disease ,business ,medicine.drug - Abstract
WOS: 000318916402451
- Published
- 2013
19. PCV42 Cost Analysis of Venous Thromboembolism Prophylaxis After Total Knee Replacement and Total Hip Replacement
- Author
-
B. Erdemli, Muzaffer Demir, T. Koksal, G. Ongen, E. Parali, M. Yuvakuran, Birsen Ince, B. Marmarali, K. Bozkurt, F. Altintas, K. Bal, G. Saka, and C. Deger
- Subjects
medicine.medical_specialty ,business.industry ,Health Policy ,Total knee replacement ,Total hip replacement ,medicine ,Cost analysis ,Public Health, Environmental and Occupational Health ,business ,Venous thromboembolism ,Surgery - Published
- 2012
- Full Text
- View/download PDF
20. Right Atrial Thrombus Mimicking Myxoma and Bilateral Pulmonary Artery Aneurysms in a Patient with Behçet's Disease—A Case Report
- Author
-
Uygun N, Ayla Gürel Sayin, Vural Fs, Buge Oz, and A K Bozkurt
- Subjects
Adult ,Male ,Hemoptysis ,medicine.medical_specialty ,Heart Diseases ,Behcet's disease ,Pulmonary Artery ,030204 cardiovascular system & hematology ,Diagnosis, Differential ,Heart Neoplasms ,03 medical and health sciences ,Fatal Outcome ,0302 clinical medicine ,Aneurysm ,medicine.artery ,medicine ,Humans ,Heart Atria ,cardiovascular diseases ,030212 general & internal medicine ,Superior vena cava syndrome ,medicine.diagnostic_test ,business.industry ,Behcet Syndrome ,Myxoma ,Thrombosis ,Magnetic resonance imaging ,medicine.disease ,Magnetic Resonance Imaging ,Surgery ,Pulmonary artery ,cardiovascular system ,medicine.symptom ,Differential diagnosis ,Cardiology and Cardiovascular Medicine ,business - Abstract
A case of Behçet's disease, in which superior vena cava syndrome was the presenting feature is reported. Magnetic resonance imaging and echocardio graphy revealed a mass lesion in the right atrium. This patient developed bilat eral pulmonary artery aneurysms postoperatively and represents one of the bizarre manifestations of Behçet's disease.
- Published
- 1993
21. Trace elements and toxic heavy metals play a role in Buerger disease and atherosclerotic peripheral arterial occlusive disease
- Author
-
C, Arslan, H, Altan, O O, Akgün, A R, Kiziler, B, Aydemir, S, Güzel, K, Besirli, and A K, Bozkurt
- Subjects
Adult ,Analysis of Variance ,Glutathione Peroxidase ,Turkey ,Iron ,Thromboangiitis Obliterans ,Arterial Occlusive Diseases ,Middle Aged ,Glutathione ,Risk Assessment ,Trace Elements ,Oxidative Stress ,Peripheral Arterial Disease ,Selenium ,Zinc ,Lead ,Risk Factors ,Malondialdehyde ,Metals, Heavy ,Humans ,Biomarkers ,Copper ,Cadmium - Abstract
The aim of the present study was to define the roles of trace elements and toxic heavy metals in Buerger disease and atherosclerotic peripheral arterial occlusive disease (PAOD).Seventy-five subjects who were identical in demographic charecteristics were selected for the study; 25 with Buerger disease, 25 with PAOD, 25 healthy volunteers. Serum selenium (Se), zinc (Zn), copper (Cu), iron (Fe),whole blood cadmium (Cd) and lead (Pb), erythrocyte glutathione (GSH), erythrocyte glutathione peroxidase (GSH-Px), erythrocyte and plasma malondialdehyde (MDA) levels were measured.Serum Se and Zn levels were significantly low in patients with Buerger disease compared to patients with PAOD and controls (P0.001 and P0.001 respectively). Serum levels of Fe and Zn were also significantly low in patients with PAOD compared to controls (p0.001 and p0.05 respectively). In contrast, Cu and Pb levels in Buerger disease group were significantly high compared to PAOD and control groups (P0.001 and P0.001 respectively). Erythrocyte GSH and GSH-Px levels were significantly lower in patients with Buerger disease compared to patients with PAOD and controls (P0.001 and P0.001 respectively), while erythrocyte and plasma MDA levels were significantly higher (P0.001 and P0.001 respectively).It can be concluded that the levels of trace elments and toxic heavy metals and oxidative stress influence the disease process in Buerger disease more than PAOD.
- Published
- 2010
22. Protection of saphenous vein graft from arterial pressure: an experimental study
- Author
-
A T, Kurdal, N, Ustundag, A, Güven, I, Iskesen, K, Bozkurt, and B H, Sirin
- Subjects
Varicose Veins ,Blood Vessel Prosthesis Implantation ,Cardiopulmonary Bypass ,Connective Tissue ,Materials Testing ,Humans ,Blood Pressure ,Saphenous Vein ,Endothelium, Vascular ,Prosthesis Design ,Polytetrafluoroethylene ,Muscle, Smooth, Vascular ,Blood Vessel Prosthesis - Abstract
Reoperations for bypass surgery increase the need for new grafts. We investigated early changes in both the normal human saphenous vein and in ectatic varicose veins externally supported by PTFE (polytetrafluoroethylene) graft and exposed to arterial pressure in an IN VITRO non-pulsatile flow model.A total of 24 saphenous vein pieces (11 of them normal, the other 13 with varicosities) with a length of 6 centimeters were divided into equal parts; half of these parts were wrapped in PTFE grafts. All vein parts were placed in a perfusion circuit. Tissue biopsies were obtained from the vein segments. Light and electron microscopy examinations were performed, and endothelial continuity, elastic laminate continuity, medial connective tissue uniformity, medial smooth muscle uniformity, and adventitial connective tissue uniformity parameters were identified.All parameters in the PTFE protected vein groups were better. The fewest morphological changes among all four groups were detected in the vein walls from normal veins with PTFE protection. There was no significant difference in endothelial continuity and adventitial connective tissue uniformity between the normal vein group and the varicose vein group with PTFE protection.It is suggested that supporting vein grafts externally with PTFE sufficiently protects the vein walls against damage from exposure to arterial pressure. If varicose veins are used as arterial grafts, supporting them with PTFE may be useful because of the good protection of endothelial and medial connective tissues, resulting in similar parameters to those of normal vein walls.
- Published
- 2009
23. Attenuation of acute lung injury following lower limb ischemia/reperfusion: the pharmacological approach
- Author
-
C, Koksal, A K, Bozkurt, N, Ustundag, D, Konukoglu, B, Musellim, G, Sirin, T, Cortelekoglu, and A G, Sayin
- Subjects
Male ,Respiratory Distress Syndrome ,L-Lactate Dehydrogenase ,Free Radical Scavengers ,Calcium Dobesilate ,Thiobarbituric Acid Reactive Substances ,Hemostatics ,Acetylcysteine ,Rats ,Rats, Sprague-Dawley ,Disease Models, Animal ,Aprotinin ,Treatment Outcome ,Lower Extremity ,Reperfusion Injury ,Animals ,Drug Therapy, Combination ,Creatine Kinase ,Biomarkers - Abstract
The purpose of this study was to examine the effects of N-acetylcysteine (NAC), calcium dobesilate (DOBE) and aprotinin on the amelioration of lung damage following ischemia/reperfusion injury in a rat hind limb model. A well known antioxidant dimethyl-sulfoxide (DMSO) was also tested for comparison.Ischemia was induced in the lower limb for 4 h by vascular clamping and followed by 1 h of reperfusion. Lung injury was evaluated in 5 groups as a saline (control), DMSO, NAC, DOBE and aprotinin group. Plasma creatine kinase, lactate dehydrogenase, thiobarbituric acid reactive substances (TBARS) as well as lung tissue TBARS levels were measured. Lung tissue samples were taken for histological examination. P0.005 was considered statistically significant.Plasma TBARS values were found to be significantly lower in the DMSO (P0.005), NAC (P0.005) and aprotinin (P0.005) groups compared to the control group. Lung TBARS values were significantly lower in the DMSO, NAC, DOBE and aprotinin groups compared to the control group (P0.001, P0.001, P0.001). Also in the aprotinin group lung TBARS values were found to be significantly lower compared to DMSO (P0.001), NAC (P0.001) and DOBE (P0.001) groups. Histological examination showed less prominent peribronchial leukostasis (P0.005) and interstitial leukostasis (P0.005) in all drug groups compared to the control group.These observations indicate that DOBE and NAC, which are known to have antioxidant properties and aprotinin, a serine proteinase inhibitor, acted effectively on the prevention of lung injury in a rat hind limb ischemia/reperfusion model. The reason why aprotinin exerts a more protective effect than the other drugs is not clear, however, its clinical use may have the dual advantage of hemostasis and lung protection in surgical practice.
- Published
- 2006
24. A randomized trial of intravenous iloprost (a stable prostacyclin analogue) versus lumbar sympathectomy in the management of Buerger's disease
- Author
-
A K, Bozkurt, C, Köksal, M Y, Demirbas, A, Erdoğan, A, Rahman, U, Demirkiliç, H, Ustünsoy, G, Metin, L, Yillik, H, Onol, B, Cinar, M, Karaçelik, I, Erdinç, C, Bolcal, and A G, Sayin
- Subjects
Adult ,Male ,Vasodilator Agents ,Lumbosacral Plexus ,Thromboangiitis Obliterans ,Middle Aged ,Treatment Outcome ,Injections, Intravenous ,Humans ,Female ,Iloprost ,Prospective Studies ,Sympathectomy ,Follow-Up Studies - Abstract
The aim of this study was to compare the effects of iloprost and lumbar sympathectomy (LS) in the treatment of Buerger's disease.Two hundred patients with rest pain and/or ischemic ulcers were randomized to undergo LS or 28-day intravenous treatment of iloprost. The primary endpoint was complete healing without pain or major amputation at 4 and 24 weeks. The secondary endpoints were analgesic requirement, reduction in the ulcer size, 50% reduction of the ulcer, and shift in the modified SVS/ISCVS clinical status grading scale.The comparison was carried out in 162 patients (iloprost: n=84; LS: n=78). Complete healing rate was 61.9% in the iloprost group, but 41% in the LS group at the 4th week (P=0.012); respective values for the 24th week were 85.3%, 52.3%, P0.001. Analgesic requirement was lower in the iloprost group at the 4th and 24th weeks (P=0.01, and P=0.098, respectively). The size of the ulcers decreased more in the iloprost group than the LS group (P=0.044 and P=0.035 at 4th and 24th weeks); 50% reduction in the ulcer size in the iloprost group was greater than in the LS group (P=0.001 and P=0.009 at 4th and 24th weeks). SVS/ISCVS grading scale demonstrated a better clinical benefit in patients treated with iloprost (P0.001 at 4th week, and P0.001 and at 24th week).The results of this independent study indicate that using iloprost relieves ischemic symptoms better than LS. In the era of stable prostacyclin analogues, there is no reliable evidence to support the use of LS in Buerger's disease.
- Published
- 2006
25. Relationship between bone scintigraphy and tumor markers in patients with breast cancer
- Author
-
Baha Oral, Azem Cobaner, Mehmet K Bozkurt, and Mustafa Yildiz
- Subjects
Oncology ,CA15-3 ,Adult ,medicine.medical_specialty ,Statistics as Topic ,CA 15-3 ,Bone Neoplasms ,Breast Neoplasms ,Technetium Tc 99m Medronate ,Breast cancer ,Internal medicine ,medicine ,Biomarkers, Tumor ,Humans ,Radiology, Nuclear Medicine and imaging ,In patient ,Radionuclide Imaging ,Tumor marker ,Aged ,medicine.diagnostic_test ,business.industry ,Disease progression ,Carcinoma ,Mucin-1 ,Bone metastasis ,General Medicine ,Middle Aged ,medicine.disease ,Carcinoembryonic Antigen ,Bone scintigraphy ,Female ,Radiology ,Radiopharmaceuticals ,business - Abstract
Purpose: The aim of this study is to specify the precise role of bone scintigraphy and serum CEA and CA 15-3 assays in the monitoring of breast cancers in order to optimize their use and to determine whether it is possible to guide the prescription of bone scan by the use of CEA and CA 15-3 assays in the monitoring of breast cancer. Methods: For this purpose, from November 1997 to May 2002, 98 consecutive female breast cancer patients (median age, 52 years; range 35-77 years) underwent bone scintigraphy during follow-up. In these patients values of tumor markers were compared with the results of bone scintigraphy. Some of the patients with bone metastasis were checked repeatedly at intervals of 6 to 12 months, resulting in 49 patients with bone metastasis and 74 patients without bone metastasis being included in the study. Results: In patients with bone metastasis, serum CEA levels were abnormal in 23/49 cases and CA 15-3 serum concentrations were elevated above the cut-off in 33/49 cases. Among patients without bone metastasis, CEA and CA 15-3 serum concentrations were normal in 50/74 and 55/74 cases respectively. The combination of the two markers improved the diagnostic sensitivity. Conclusion: Although serial tumor marker measurements are an efficient and cost effective method of monitoring disease progression, it does not allow prediction of the bone scan results; so it is not justifiable to reject a bone scintigraphy on the basis of these markers.
- Published
- 2004
26. Cardiac echinococcosis in a 3-year-old child
- Author
-
A K, Bozkurt and C, Köksal
- Subjects
Echinococcosis, Hepatic ,Heart Diseases ,Echinococcosis ,Child, Preschool ,Humans ,Female ,Magnetic Resonance Imaging ,Splenic Diseases - Abstract
A 3-year-old girl was admitted with the diagnosis of left ventricular hydatid cyst. She also had pulmonary, hepatic and splenic cysts. The diagnosis of the left ventricular cyst was made by means of computerized tomography and confirmed using cardiac magnetic resonance imaging and transthoracic echocardiography. The patient was submitted to cystectomy on beating heart with a straightforward postoperative period.
- Published
- 2004
27. Comparison of hydrosonography and diagnostic hysteroscopy in the evaluation of infertile patients
- Author
-
M S, Yucebilgin, E, Aktan, K, Bozkurt, M, Kazandi, F, Akercan, L, Mgoyi, and M C, Terek
- Subjects
Adult ,Uterine Diseases ,Endometrium ,Humans ,Female ,Hysteroscopy ,Infertility, Female ,Sensitivity and Specificity ,Retrospective Studies ,Ultrasonography - Abstract
In the present study we evaluated the value of hydrosonography in the screening for intracavitary structural pathologies in patients with a history of infertility before the implementation of assisted-reproductive technology. Hysterescopy was regarded as the gold standard procedure.A retrospective study.A total number of 115 infertile women aged between 19 and 47 (33.4 +/- 5.3), who were candidates for assisted reproductive techniques, were enrolled in this retrospective analysis. The study comprised data obtained from patients undergoing infertility investigation between 2001 and 2003 at Ozel Ege IVF Center and the Department of Obstetrics and Gynecology of Ege University Faculty of Medicine. The results obtained by hydrosonography were later compared with those of hysteroscopy. Sensitivity, specificity, positive predictive value and negative predictive value for hydrosonography were calculated.In a total of 115 women, 53 (46%), 24 (20%), 30 (26%) and 8 (7%) were found to have normal endometrial cavities, submucous myoma, endometrial polyps and uterine septum, respectively, on hydrosonography. Forty-five (85%) of 53 women, who were supposed to have normal findings on hydrosonography, were confirmed by hysteroscopy. In the remaining eight women (15%), two had endometrial polyps, three had uterine septum, one had submucous myoma and two had intrauterine synechia on hysteroscopic examinations. The sensitivity, specificity, positive and negative predictive values of hydrosonography in the detection of structural endometrial cavity lesions were 85%, 75%, 75% and 84%, respectively. Two intrauterine adhesions were not recognized by hydrosonography.Hydrosonography may be a useful tool in the evaluation of intrauterine cavity structural pathologies in infertile patients with the exception of intrauterine adhesions. In addition, hydrosonography was found to be sensitive in the detection of intrauterine septum.
- Published
- 2004
28. Impaired plasma viscosity via increased cholesterol levels in peripheral occlusive arterial disease [correction of disase]
- Author
-
M, Ercan, C, Koksal, D, Konukoglu, A K, Bozkurt, and S, Onen
- Subjects
Male ,Lipoproteins ,Cholesterol, HDL ,Hypercholesterolemia ,Arterial Occlusive Diseases ,Cholesterol, LDL ,Middle Aged ,Lipids ,Apolipoproteins ,Risk Factors ,Humans ,Female ,Rheology ,Triglycerides ,Aged - Abstract
The aim of this study was to investigate the relationship between plasma viscosity and lipoprotein and apolipoprotein pattern in normo- and hypercholesterolemic patients with peripheral occlusive arterial disease (POAD). 40 patients with POAD have been selected (8 females and 32 males, mean age: 54+/-3.2 years) with clinically evident superficial femoral occlusive artery disease. They were separated into two groups as normocholesterolemic (plasma total cholesterol200 mg/dl) and hypercholesterolemic (plasma total cholesterol200 mg/dl). Plasma total cholesterol, high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), triglycerides, total protein, and albumin levels were determined by enzymatic methods using commercial kits. Levels of apolipoprotein AI (apo AI), and apolipoprotein B (apo B) were measured using a immunoturbidometric method. Plasma viscosity (PV) was measured by capillary viscometer. Classifying the patients with PAOD according to the cholesterol levels; hypercholesterolemic (mean total-cholesterol: 227.90+/-26.97 mg/dl) patients had significantly higher LDL-C, PV and triglyceride levels compared with nornocholesterolemic patients (p0.001, p0.001, p0.001, respectively). HDL-C and apo B were significantly lower in hypercholesterolemic patients than in normocholesterolemic patients (p0.001, p0.001, respectively). PV was positively correlated with total cholesterol (r=0.485, p0.05), atherogenic index (r=0.624, p0.01), total-C/HDL-C ratio (r=0.624, p0.05), and LDL-C/HDL-C ratio (r=0.707, p0.001) in hypercholesterolemic patients with POAD. PV was higher in hypercholesterolemic patients with POAD than in normocholesterolemic patients with POAD. We suggest that POAD patients should be regarded as a heterogenous group with lipid and lipoprotein parameters in order to assess the microcirculation in the affected limb. In case of dyslipidemia in POAD patients an elevated plasma viscosity should be considered as coexisting risk factor.
- Published
- 2003
29. Hemorrheological variables in critical limb ischemia
- Author
-
C, Köksal, M, Ercan, and A K, Bozkurt
- Subjects
Male ,Peripheral Vascular Diseases ,Leg ,Erythrocytes ,Arterial Occlusive Diseases ,Middle Aged ,Blood Viscosity ,Elasticity ,Femoral Artery ,Plasma ,Hemorheology ,Humans ,Female ,Hypoxia ,Muscle, Skeletal - Abstract
Impaired hemorrheological properties may worsen the tissue hypoxia distal to an arterial narrowing in patients with peripheral arterial occlusive disease (PAOD). The objective of this study was to investigate the changes in red blood cell rigidity, blood viscosity and plasma viscosity as contributing factors in the development of hypoxia in patients with critical limb ischemia (CLI).Forty patients with critical limb ischemia and 40 healthy subjects were included in the study. The subjects included in the study were non-diabetic with blood pressure measurements within the normal range. Compound known to interfere with hemorrheological parameters were not taken by the patients for at least 7 days prior to investigation. Routine blood counts (WBC, RBC, Hb, Hct), plasma fibrinogen levels, plasma total cholesterol levels, red blood cell rigidity, blood and plasma viscosity were determined in both groups. Statistical evaluation of the results of both groups was compared by student's "t"-test. The level of significance was set at p0.05.Blood viscosity at a shear rate of 6.00 sec(-1) was found to be significantly lower in the CLI group (p0.001), whereas no significant difference was encountered when blood viscosity was measured at a shear rate of 225 sec(-1). Plasma viscosity and plasma fibrinogen levels were comparable. Plasma total cholesterol levels were found to be significantly higher in the CLI group (p0.05) and red blood cell rigidity significantly lower (p0.001).These findings may provide new insights into the role of blood viscosity in patients with CLI contrary to the previous reports in the literature. Therapies that address red blood cell rigidity more directly may decrease tissue hypoxia distal to arterial narrowing by preventing hemolysis, improving microcirculation, and increasing oxygen carrying capacity and may be more beneficial for these patients.
- Published
- 2003
30. Calcium dobesilate ameliorates lung injury following lower limb ischemia/reperfusion
- Author
-
A K, Bozkurt, D, Konukoğlu, N, Ustündağ, L, Yüceyar, and A S, Mayda
- Subjects
Male ,Rats, Sprague-Dawley ,Lower Extremity ,Ischemia ,Reperfusion Injury ,Animals ,Calcium Dobesilate ,Lung ,Rats - Abstract
We examined the effects of calcium dobesilate on ameliorating the lung damage following ischemia-reperfusion injury in skeletal muscle of rats. A well known antioxidant, dimethyl sulfoxide, was also tested for comparison. The study included three groups: normal saline, dimethyl sulfoxide and calcium dobesilate. Plasma bicarbonate, creatine kinase, lactate dehydrogenase, thiobarbituric acid reactive substances (TBARS), as well as muscle and lung tissue TBARS levels were measured. Lung tissue samples were taken for histological examination. The dimethyl sulfoxide group showed significant amelioration of plasma (p = 0.004), skeletal muscle (p = 0.006) and lung TBARS (p = 0.004) levels, compared with controls. Calcium dobesilate-treated rats showed significantly low level muscle (p = 0.025) and lung TBARS (p = 0.004), compared with the control group. The extent of lung injury according to the histological findings was less in the dimethyl sulfoxide (p = 0.004) and calcium dobesilate (p = 0.003) groups. These observations indicated that calcium dobesilate acted effectively in the prevention of lung damage following ischemia-reperfusion injury in the rat skeletal muscle.
- Published
- 2003
31. Alpha-tocopherol (Vitamin E) and iloprost attenuate reperfusion injury in skeletal muscle ischemia/reperfusion injury
- Author
-
A K, Bozkurt
- Subjects
Male ,Rats, Sprague-Dawley ,Random Allocation ,Reperfusion Injury ,Vasodilator Agents ,Animals ,Vitamin E ,Iloprost ,Lipid Peroxidation ,Antioxidants ,Rats - Abstract
The aim of this study was to clarify the role of a-tocopherol (vitamin E) and iloprost on skeletal muscle ischemia/reperfusion injury.animal research laboratory of a university hospital.the iliac arteries of the 24 adult Sprague-Dawley rats were clamped and 4 hours of ischemia followed by 1 hour of reperfusion was applied. In an attempt to decrease reperfusion injury, the rats were given either a-tocopherol (n=8), iloprost (n=6) and 8 rats were given normal saline and served as control group (n=8).blood pH, pO2, pCO2, HCO3, Na, K, creatine kinase (CPK), lactate dehydrogenase (LDH) values were determined at the end of the reperfusion period. Malondialdehyde (MDA), a product of lipid peroxidation, was measured in blood, muscle and lung as an indicator of free radicals.Blood pO2 and HCO3 levels were significantly high (p0.05); CPK, LDH and MDA levels were significantly low (p0.05) in both a-tocopherol and iloprost groups when compared to the control group. Similarly, the MDA levels in the gastrocnemius muscle were significantly low in both treatment groups when compared to the controls (p0.05). There was no significant difference between groups in other parameters.The results suggest that, both a-tocopherol and iloprost are useful for attenuating oxidative muscle damage occurring after a period of ischemia/ reperfusion.
- Published
- 2002
32. Schwannoma as a cause of Pancoast's syndrome
- Author
-
A K, Bozkurt
- Subjects
Adult ,Lung Neoplasms ,Treatment Outcome ,Biopsy, Needle ,Humans ,Female ,Pancoast Syndrome ,Tomography, X-Ray Computed ,Magnetic Resonance Imaging ,Neurilemmoma ,Follow-Up Studies - Published
- 2002
33. Subcutaneous hydatidosis due to iatrogenic spreading of cystic fluid during surgery
- Author
-
A K, Bozkurt, N, Yavuz, and L, Yüceyar
- Subjects
Adult ,Diagnosis, Differential ,Cicatrix ,Echinococcosis, Hepatic ,Echinococcosis ,Abdomen ,Iatrogenic Disease ,Humans ,Female ,Skin Diseases, Parasitic ,Tomography, X-Ray Computed - Abstract
Subcutaneous involvement is a rare manifestation of echinococcosis. We report a rare case of a 28-year-old woman with widespread hydatidosis of the lung, liver, and subcutaneous adipose tissue. The patient underwent surgical excision of multiple hepatic and pulmonary cysts with a thoraco-abdominal incision two years earlier. The subcutaneous cyst was located over the incision, and it is likely that resulted from accidental rupture of the primary cyst and spreading of scolices during surgery.
- Published
- 2001
34. A brachial aneurysm in childhood caused by Ehlers-Danlos syndrome
- Author
-
A G, Sayin, A K, Bozkurt, U, Cangel, C, Köksal, and B, Oz
- Subjects
Male ,Brachial Artery ,Humans ,Ehlers-Danlos Syndrome ,Ultrasonography, Doppler, Color ,Child ,Aneurysm ,Ligation - Abstract
A case of an 11-year-old boy with Ehlers-Danlos syndrome (EDS) type IV is presented. He was referred with a pulsatile mass above the right antecubital fossa and Doppler revealed a saccular aneurysm. Excision and ligation of the brachial artery aneurysm was performed. The diagnosis was confirmed by skin fibroblast cultures and histopathologic evaluation. We conclude that arteriography should be avoided in EDS and color-Doppler should be the sole means of diagnosis. Ligation rather than arterial reconstruction should be preferred.
- Published
- 2001
35. The cost–effectiveness of rivaroxaban for the prevention of stroke in patients with atrial fibrillation (AF) in Turkey
- Author
-
Hakan Kültürsay, M.O. Ozel, B. Marmarali, Birsen Ince, Oktay Özdemir, K. Bozkurt, Z.S. Yilmaz, Muzaffer Demir, E. Tuna, F. Sumer, E. Parali, C. Deger, G. Ongen, Zeki Öngen, and Ege Üniversitesi
- Subjects
Rivaroxaban ,medicine.medical_specialty ,Cost effectiveness ,business.industry ,Health Policy ,Public Health, Environmental and Occupational Health ,Atrial fibrillation ,medicine.disease ,Internal medicine ,medicine ,Cardiology ,In patient ,business ,Stroke ,health care economics and organizations ,medicine.drug - Abstract
WOS: 000318916402439
- Published
- 2013
36. [The effect of dehydroepiandrosterone sulfate on cervical maturation during pregnancy]
- Author
-
F, Koyuncu, S, Aksoy, C, Karanfil, N, Demir, K, Bozkurt, and G, Tuncay
- Subjects
Adult ,Adolescent ,Hydrocortisone ,Dehydroepiandrosterone Sulfate ,Estrogens ,Cervix Uteri ,Dehydroepiandrosterone ,Predictive Value of Tests ,Pregnancy ,Humans ,Labor Onset ,Female ,Labor, Induced ,Progesterone - Abstract
Steroid hormones would have an effect on the duration of pregnancy. Venous blood was drawn in 90 patients who were scheduled for provoked delivery for assay of serum dehydroepiandrosterone sulphate (S-DHEA), oestrogen, progesterone and cortisol. Serum concentration of S-DHEA was significantly higher (p0.005) in women with a favourable Bishop score (6) compared with those with an unfavourable score. These findings suggest that a rise in S-DHEA level occurs before modifications in the cervix.
- Published
- 1995
37. Thyroid hemiagenesis
- Author
-
Mehmet K Bozkurt and Mustafa Yildiz
- Subjects
Male ,Thyroid Hormones ,Palpation ,Adolescent ,Turkey ,Goiter ,business.industry ,Biopsy, Fine-Needle ,Thyroid Gland ,Public Health, Environmental and Occupational Health ,Embryonic and Fetal Development ,Psychiatry and Mental health ,Pediatrics, Perinatology and Child Health ,Humans ,Medicine ,Radionuclide Imaging ,business ,Ultrasonography - Published
- 2003
38. Surgical treatment of Buerger's disease: experience with 216 patients
- Author
-
A, Sayin, A K, Bozkurt, H, Tüzün, F S, Vural, G, Erdog, and M, Ozer
- Subjects
Adult ,Male ,Leg ,Ischemia ,Angiography ,Humans ,Thromboangiitis Obliterans ,Female ,Arteries ,Middle Aged ,Sympathectomy ,Amputation, Surgical ,Retrospective Studies - Abstract
Buerger's disease (thromboangiitis obliterans) is a rare peripheral vascular disease that usually affects young male smokers. It is characterized by multiple occlusions distal to the knee and elbow. Although rarely encountered in this condition, major arterial occlusions can be corrected by arterial revascularization. The hospital records of 216 patients (214 men and 2 women) with Buerger's disease were reviewed retrospectively, 142 (66%) between 1 and 120 (mean(s.d.) 72.8(24)) months after diagnosis. Of these patients 21 had had an arterial revascularization; 183 lumbar and 20 thoracic sympathectomies had been performed. In 30 of the patients a total of 29 minor and four major amputations had been performed. In appropriate cases arterial reconstruction provides better healing of ischaemic lesions. Although vasomotor tone is usually normalized in 2 weeks to 6 months after sympathectomy, the temporary increase in blood flow is often sufficient to heal ischaemic lesions during this period.
- Published
- 1993
39. Embolisation in Behcet's disease
- Author
-
A K Bozkurt
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,business.industry ,education ,Disease ,Behcet's disease ,medicine.disease ,humanities ,Surgery ,Aneurysm ,medicine.artery ,Pulmonary artery ,medicine ,business - Abstract
I read with interest the excellent review of Behcet's disease by Erkan et al 1 and wish to comment on the treatment of pulmonary artery aneurysms (PAA) with embolisation. Durieux et al reported the first case in 1981, and a further four successfully treated cases have been reported since 1985.2–5 As reported by others,6–8 we have found …
- Published
- 2002
40. Liver involvement in patients with brucellosis: results of the Marmara study
- Author
-
D. Ozturk-Engin, H. Erdem, S. Gencer, S. Kaya, A. I. Baran, A. Batirel, R. Tekin, M. K. Celen, A. Denk, S. Guler, M. Ulug, H. Turan, A. U. Pekok, G. Mermut, M. Tasbakan, N. Tulek, Y. Cag, A. Inan, A. Yalci, C. Ataman-Hatipoglu, I. Gonen, A. Dogan-Celik, F. Bozkurt, S. Gulsun, M. Sunnetcioglu, T. Guven, F. Duygu, E. Parlak, H. Sozen, S. Tosun, T. Demirdal, E. Guclu, O. Karabay, N. Uzun, O. Gunal, H. Diktas, A. Haykir-Solay, A. Erbay, C. Kader, O. Aydin, A. Erdem, N. Elaldi, A. Kadanali, Z. Yulugkural, L. Gorenek, M. Altındis, S. Bolukcu, C. Agalar, N. Ormeci, Ozturk-Engin, D, Erdem, H, Gencer, S, Kaya, S, Baran, AI, Batirel, A, Tekin, R, Celen, MK, Denk, A, Guler, S, Ulug, M, Turan, H, Pekok, AU, Mermut, G, Tasbakan, M, Tulek, N, Cag, Y, Inan, A, Yalci, A, Ataman-Hatipoglu, C, Gonen, I, Sakarya Üniversitesi/İlahiyat Fakültesi/Temel İslam Bilimleri Bölümü, Kaya, Süleyman, [Ozturk-Engin, D. -- Inan, A. -- Bolukcu, S.] Haydarpasa Numune Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Istanbul, Turkey -- [Erdem, H. -- Gorenek, L.] GATA Haydarpasa Training Hosp, Dept Infect Dis & Clin Microbiol, Istanbul, Turkey -- [Gencer, S. -- Batirel, A. -- Cag, Y.] Lutfi Kirdar Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Istanbul, Turkey -- [Kaya, S. -- Gulsun, S.] Diyarbakir Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Diyarbakir, Turkey -- [Baran, A. I. -- Sunnetcioglu, M.] Yuzuncu Yil Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Van, Turkey -- [Tekin, R. -- Celen, M. K. -- Bozkurt, F.] Dicle Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Diyarbakir, Turkey -- [Denk, A.] Firat Univ, Sch Med, Dept Infect Dis & Clin Microbiol, TR-23169 Elazig, Turkey -- [Guler, S.] Yenisehir State Hosp, Dept Infect Dis & Clin Microbiol, Kahramanmaras, Turkey -- [Ulug, M.] Private Umit Hosp, Dept Infect Dis & Clin Microbiol, Eskisehir, Turkey -- [Turan, H.] Baskent Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Konya, Turkey -- [Pekok, A. U.] Private Erzurum Sifa Hosp, Dept Infect Dis & Clin Microbiol, Erzurum, Turkey -- [Mermut, G. -- Tosun, S.] Izmir Bozyaka Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Izmir, Turkey -- [Kaya, S.] Karadeniz Tech Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Trabzon, Turkey -- [Tasbakan, M.] Ege Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Izmir, Turkey -- [Tulek, N. -- Ataman-Hatipoglu, C.] Ankara Numune Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Ankara, Turkey -- [Yalci, A.] Ankara Univ, Sch Med, Dept Infect Dis & Clin Microbiol, TR-06100 Ankara, Turkey -- [Gonen, I.] Suleyman Demirel Univ, Sch Med, Dept Infect Dis & Clin Microbiol, TR-32200 Isparta, Turkey -- [Dogan-Celik, A. -- Yulugkural, Z.] Trakya Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Edirne, Turkey -- [Guven, T.] Yildirim Beyazit Univ, Ankara Ataturk Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Ankara, Turkey -- [Duygu, F. -- Gunal, O.] Gaziosmanpasa Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Tokat, Turkey -- [Parlak, E.] Ataturk Univ, Dept Infect Dis & Clin Microbiol, Sch Med, Erzurum, Turkey -- [Sozen, H.] Sitki Kocman Univ, Sch Med, Dept Anesthesiol & Reanimat, Mugla, Turkey -- [Demirdal, T.] Katip Celebi Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Izmir, Turkey -- [Guclu, E. -- Karabay, O.] Sakarya Univ, Dept Infect Dis & Clin Microbiol, Sch Med, Sakarya, Turkey -- [Uzun, N.] Sisli Etfal Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Istanbul, Turkey -- [Diktas, H.] Tatvan Mil Hosp, Dept Infect Dis & Clin Microbiol, Istanbul, Turkey -- [Haykir-Solay, A.] Igdir State Hosp, Dept Infect Dis & Clin Microbiol, Igdir, Turkey -- [Erbay, A. -- Kader, C.] Bozok Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Yozgat, Turkey -- [Aydin, O.] Medeniyet Univ, Dept Infect Dis & Clin Microbiol, Goztepe Training & Res Hosp, Istanbul, Turkey -- [Erdem, A.] Medeniyet Univ, Dept Pathol, Goztepe Training & Res Hosp, Istanbul, Turkey -- [Elaldi, N.] Cumhuriyet Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Sivas, Turkey -- [Kadanali, A.] Umraniye Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Istanbul, Turkey -- [Altindis, M.] Sakarya Univ, Sch Med, Dept Clin Microbiol, Sakarya, Turkey -- [Agalar, C.] Fatih Sultan Mehmet Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Istanbul, Turkey -- [Ormeci, N.] Ankara Univ, Sch Med, Dept Gastroenterol, TR-06100 Ankara, Turkey, Gencer, Serap -- 0000-0002-3217-6305, Altindis, Mustafa -- 0000-0003-0411-9669, GENCER, SERAP -- 0000-0002-3217-6305, Elaldi, Nazif -- 0000-0002-9515-770X, and Karabay, Oguz -- 0000-0003-0502-432X
- Subjects
Microbiology (medical) ,Adult ,Male ,medicine.medical_specialty ,Anemia ,Gastroenterology ,Brucellosis ,Hepatitis ,Young Adult ,Internal medicine ,medicine ,Animals ,Humans ,Leukocytosis ,Transaminases ,Retrospective Studies ,Doxycycline ,Leukopenia ,business.industry ,Bilirubin ,General Medicine ,Middle Aged ,medicine.disease ,Pancytopenia ,Surgery ,Anti-Bacterial Agents ,Infectious Diseases ,Treatment Outcome ,Female ,medicine.symptom ,business ,Rifampicin ,medicine.drug - Abstract
WOS: 000336986700024, PubMed ID: 24557334, Brucellosis is a zoonotic disease that primarily affects the reticuloendothelial system. But, the extent of liver damage in due course of the disease is unclear. This study included 325 brucellosis patients with significant hepatobiliary involvement identified with microbiological analyses from 30 centers between 2000 and 2013. The patients with a parts per thousand yen5 times of the upper limit of normal for aminotransferases, total bilirubin level a parts per thousand yen2 mg/dl or local liver lesions were enrolled. Clinical hepatitis was detected in 284 patients (87.3 %) and cholestasis was detected in 215 (66.1 %) patients. Fatigue (91 %), fever (86 %), sweating (83 %), arthralgia (79 %), and lack of appetite (79 %) were the major symptoms. Laboratory tests showed anemia in 169 (52 %), thrombocytopenia in 117 (36 %), leukopenia in 81 (25 %), pancytopenia in 42 (13 %), and leukocytosis in 20 (6 %) patients. The most commonly used antibiotic combinations were doxycycline plus an aminoglycoside (n = 73), doxycycline plus rifampicin (n = 71), doxycycline plus rifampicin and an aminoglycoside (n = 27). The duration of ALT normalization differed significantly in three treatment groups (p < 0.001). The use of doxycycline and an aminoglycoside in clinical hepatitis showed better results compared to doxycycline and rifampicin or rifampicin, aminoglycoside, doxycycline regimens (p < 0.05). However, the length of hospital stay did not differ significantly between these three combinations (p > 0.05). During the follow-up, treatment failure occurred in four patients (1 %) and relapse was seen in three patients (0.9 %). Mortality was not observed. Hepatobiliary involvement in brucellosis has a benign course with suitable antibiotics and the use of doxycycline and an aminoglycoside regimen seems a better strategy in select patients.
- Published
- 2014
41. Cardiovascular Insights for the Appropriate Management of Chronic Venous Disease: A Narrative Review of Implications for the Use of Venoactive Drugs.
- Author
-
Gianesini S, De Luca L, Feodor T, Taha W, Bozkurt K, and Lurie F
- Subjects
- Humans, Quality of Life, Chronic Disease, Flavonoids therapeutic use, Inflammation drug therapy, Venous Insufficiency complications, Venous Insufficiency drug therapy, Cardiovascular Diseases complications, Cardiovascular Diseases drug therapy, Venous Thromboembolism drug therapy, Vascular Diseases drug therapy
- Abstract
Evidence suggests that chronic venous disease (CVD) may be a cardiovascular disorder, as patients with CVD are prone to developing arterial (atherosclerosis) and venous (thromboembolism) diseases. This may be partly explained by shared risk factors. Thus, patients with CVD or cardiovascular disease require careful history-taking and physical assessment to identify coexisting pathologies and risk factors. This article summarises a symposium at the XIX World Congress of the International Union of Phlebology held in Istanbul, Turkey, in September 2022. Common pathophysiological features of CVD and cardiovascular disease are endothelial injury, hypercoagulability and systemic inflammation. In CVD, inflammation primarily affects the microcirculation, with changes in capillary permeability, vein wall and valve remodelling and increase in oxidative stress. Once patients develop symptoms/signs of CVD, they tend to reduce their physical activity, which may contribute to increased risk of cardiovascular disease. Data show that the presence of CVD is associated with an increased risk of cardiovascular disease, including peripheral arterial disease and heart failure (HF), and the risk of adverse cardiovascular events increases with CVD severity. In addition, patients with cardiovascular disease, particularly those with HF, are at increased risk of venous thromboembolism (VTE) and should be assessed for VTE risk if they are hospitalised with cardiovascular disease. Therefore, CVD management must include a multi-specialty approach to assess risk factors associated with both the venous and arterial systems. Ideally, treatment should focus on the resolution of endothelial inflammation to control both CVD and cardiovascular disease. International guidelines recommend various conservative treatments, including venoactive drugs (VADs), to improve the symptoms/signs of CVD. Micronized purified flavonoid fraction (MPFF) is a VAD, with high-quality evidence supporting its use in relieving symptoms/signs of CVD and improving quality of life. Moreover, in large-scale observational studies, MPFF has shown superior effectiveness in real-world populations compared with other VADs. Video Abstract. (MP4 97173 kb)., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
42. Diagnostic criteria for Buerger's disease: International Consensus of VAS - European Independent Foundation in Angiology/Vascular Medicine.
- Author
-
Fazeli B, Poredos P, Kozak M, Pecsvarady Z, Catalano M, Al Salman MM, Altarazi L, Ali AA, Bashar AH, Bozkurt K, Cacione D, Chua B, Cvjetko I, Desai S, Erer D, Farkas K, Gaddikeri P, Geroulakos G, Guclu O, Hussein E, Ionac M, Iwai T, Karahan O, Kashani D, Kota A, Kroger K, Kubat E, Kumar PP, Lang W, Lobastov K, Malecki R, Marcoccia A, Ozbakkaloglu A, Pandey SR, Patel M, Polat A, Rajeev A, Ravari H, Samuel V, Schernthaner G, Selvaraj D, Sanri US, Sermsathanasawadi N, Sharebiani H, Stanek A, Stephen E, Szuba A, Taha W, Taheri H, Wautrecht JC, Yuwono HS, Zor MH, and Liew A
- Subjects
- Humans, Middle Aged, Smoking, Angiography, Thromboangiitis Obliterans diagnosis
- Abstract
Buerger's disease (BD) remains a debilitating condition and early diagnosis is paramount for its effective management. Despite many published diagnostic criteria for BD, selective criteria have been utilized in different vascular centers to manage patients with BD worldwide. A recent international Delphi Consensus Study on the diagnostic criteria of BD showed that none of these published diagnostic criteria have been universally accepted as a gold standard. Apart from the presence of smoking, these published diagnostic criteria have distinct differences between them, rendering the direct comparison of patient outcomes difficult. Hence, the expert committees from the Working Group of the VAS-European Independent Foundation in Angiology/Vascular Medicine critically reviewed the findings from the Delphi study and provided practical recommendations on the diagnostic criteria for BD, facilitating its universal use. We recommend that the 'definitive' diagnosis of BD must require the presence of three features (history of smoking, typical angiographic features and typical histopathological features) and the use of a combination of major and minor criteria for the 'suspected' diagnosis of BD. The major criterion is the history of active tobacco smoking. The five minor criteria are disease onset at age less than 45 years, ischemic involvement of the lower limbs, ischemic involvement of one or both of the upper limbs, thrombophlebitis migrans and red-blue shade of purple discoloration on edematous toes or fingers. We recommend that a 'suspected' diagnosis of BD is confirmed in the presence of a major criterion plus four or more minor criteria. In the absence of the major criterion or in cases of fewer than four minor criteria, imaging and laboratory data could facilitate the diagnosis. Validation studies on the use of these major and minor criteria are underway.
- Published
- 2023
- Full Text
- View/download PDF
43. Tracheitis Diagnosed With 68 Ga-PSMA PET/CT in a Patient With COVID-19.
- Author
-
Aksu A, Bozkurt K, and Yılmaz B
- Subjects
- Gallium Radioisotopes, Humans, Male, Middle Aged, Positron Emission Tomography Computed Tomography methods, Prostate-Specific Antigen, COVID-19 complications, COVID-19 diagnostic imaging, Prostatic Neoplasms complications, Prostatic Neoplasms diagnostic imaging, Tracheitis
- Abstract
Abstract: A 57-year-old man with newly diagnosed with prostate cancer was admitted to our department for 68 Ga-prostate-specific membrane antigen PET/CT imaging. The patient, who was asymptomatic at the time of imaging, had increased diffuse 68 Ga-prostate-specific membrane antigen uptake in the trachea on PET/CT. No ground-glass density suggestive of pneumonia in both lungs was observed. The patient, whose symptoms developed 2 days after PET/CT imaging, was diagnosed with coronavirus disease 2019 by real-time polymerase chain reaction., Competing Interests: Conflicts of interest and sources of funding: none declared., (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
44. Ocular changes in nephrotic syndrome patients with preserved renal functions.
- Author
-
Ceri M, Pekel G, Mert M, Bozkurt K, Tas MY, and Dursun B
- Subjects
- Choroid blood supply, Choroid diagnostic imaging, Cross-Sectional Studies, Humans, Kidney physiology, Tomography, Optical Coherence methods, Nephrotic Syndrome complications, Photochemotherapy methods
- Abstract
Background: Optical coherence tomography (OCT) measurements of central choroidal thickness (CCT) and retinal thickness have been proposed as inflammatory indicators for a variety of systemic disorders, particularly those with a vascular component. The relationship between nephrotic syndrome (NS) and visual impairment is not clear. The aim of this study was to evaluate the ocular changes in primary NS patients with preserved renal functions., Methods: A total of 60 participants (30 NS patients, 30 healthy control subjects) was recruited in this cross-sectional and comparative study. Retinal and choroidal examinations were performed via the spectral domain OCT. Enhanced depth imaging (EDI) mode of the OCT was used for choroidal analysis., Results: Although not statistically significant, CCT was found to be higher in the NS group compared to the control group (p = 0.07). Central foveal thickness (CFT) and retinal arteriolar caliber (RAC) values were statistically significantly lower in the patients with nephrotic syndrome, whereas retinal venular caliber (RVC) and choroidal vascularity index (CVI) values were similar in both groups. RAC and RVC were not statistically significantly correlated with CCT or CFT in both groups (p > 0.05)., Conclusion: The results of the current study showed a significant difference between the NS group and the control group in terms of some ocular changes (i.e., CFT and RAC). As a result, CCT, CFT and RAC measurements with OCT may be used as a marker of inflammation in NS patients., (Copyright © 2022. Published by Elsevier B.V.)
- Published
- 2022
- Full Text
- View/download PDF
45. Corneal and lenticular clarity in children with inflammatory disease as assessed by Scheimpflug imaging.
- Author
-
Cetin EN, Akbulut S, Ekici Tekin Z, Otar Yener G, Bozkurt K, Pekel G, and Yüksel S
- Subjects
- Adolescent, Child, Diagnostic Imaging, Endothelium, Corneal diagnostic imaging, Female, Humans, Inflammation diagnostic imaging, Photochemotherapy methods, Uveitis
- Abstract
Background: Corneal and lenticular optical properties are not well-documented in pediatric patients with inflammatory diseases. Here we aimed to evaluate corneal and lenticular optical density as well as corneal morphology in children with ocular and/or systemic inflammation by Scheimpflug imaging., Methods: Fifty-five eyes of 29 children with non-infectious uveitis, 56 eyes of 28 children with systemic inflammation without uveitis and 60 eyes of 31 healthy children were included. Corneal/lenticular optical density, corneal volume, central corneal thickness, keratometry were analyzed by Pentacam HR. Corneal endothelial cell density, hexagonal cell ratio and coefficient of variation were measured by specular microscope., Results: The mean age was 12.0 ± 3.1 years, 11.9 ± 4.0 years and 11.3 ± 3.4 years whereas the female/ratio was 15/14, 15/13 and 14/17 in uveitis, systemic inflammation and control groups respectively. Uveitis type was anterior uveitis in 16 (29.1%) eyes, intermediate uveitis in 32 (58.2%) eyes and panuveitis in 7 (12.7%) eyes. Twenty-two (40%) eyes had active uveitis whereas 33 (60%) eyes had inactive uveitis. Corneal optical density was greater in uveitis group compared with other groups (p = 0.001, Kruskal-Wallis test). Lenticular density and corneal parameters other than optical density were not different between the groups (p > 0.05). Corneal optical density was higher in active uveitis than inactive uveitis (22/33 eyes, p = 0.017)., Conclusion: Children with uveitis had decreased corneal clarity compared with systemic inflammation group and healthy controls, while lenticular clarity was similar between the groups. Corneal endothelial parameters did not change significantly based on ocular/systemic inflammation. Scheimpflug imaging provides objective corneal and lenticular optical density measurements., (Copyright © 2022. Published by Elsevier B.V.)
- Published
- 2022
- Full Text
- View/download PDF
46. Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study.
- Author
-
Holmes P, Bell HE, Bozkurt K, Catarig AM, Clark A, Machell A, and Sathyapalan T
- Abstract
Introduction: Once-weekly (OW) semaglutide was associated with clinically relevant improvements in glycaemic control and body weight versus comparators in the SUSTAIN randomised controlled trials (RCTs). SURE UK, which is one of a series of individual studies that comprise the SURE programme, evaluated the use of OW semaglutide in a real-world patient population with type 2 diabetes (T2D) in the UK., Methods: In this prospective, observational study, adults (≥ 18 years) with ≥ 1 documented glycated haemoglobin (HbA
1c ) value ≤ 12 weeks before semaglutide initiation were enrolled. The primary endpoint was change in HbA1c from baseline to end of study (EOS; ~ 30 weeks, although due to the COVID-19 pandemic, visits up to week 52 were permitted). Secondary endpoints included change in body weight, waist circumference and patient-reported outcomes (PROs). Physicians were to report all episodes of documented or severe hypoglycaemia, fatal events, serious adverse drug reactions, pregnancies and adverse events (AEs) in foetuses/newborn infants; other AEs during the study period could be reported on a voluntary basis., Result: The estimated mean change in HbA1c from baseline to EOS was - 16.3 mmol/mol [95% confidence interval (CI): - 18.22, - 14.37] (- 1.5%-points [95% CI - 1.67, - 1.31]; p < 0.0001) among the 171 enrolled patients who completed the study on treatment. Mean body weight change was - 5.8 kg (95% CI - 6.75, - 4.94; p < 0.0001). Sensitivity analyses showed similar results. Improvements were also observed in other secondary endpoints, including PROs. No new safety concerns were identified with semaglutide treatment., Conclusion: Patients receiving OW semaglutide experienced statistically significant and clinically relevant reductions from baseline in HbA1c and body weight. These results are in line with those of the SUSTAIN RCTs and support the use of OW semaglutide in routine clinical practice in adults with T2D in the UK., Trial Registration: ClinicalTrials.gov Identifier NCT03876015., (© 2021. The Author(s).)- Published
- 2021
- Full Text
- View/download PDF
47. Corneal and anterior chamber morphology in patients with nonınfectious ıntraocular ınflammation.
- Author
-
Cetin EN, Bozkurt K, Akbulut S, Pekel G, Taşcı M, and Çobankara V
- Subjects
- Cornea, Humans, Inflammation, Microscopy, Anterior Chamber, Uveitis
- Abstract
Purpose: To evaluate the corneal and anterior chamber morphology in phakic eyes with noninfectious intraocular inflammation., Methods: This study included 59 eyes with active uveitis, 62 with inactive uveitis, and 95 healthy eyes. Corneal endothelial cell density, hexagonal cell ratio, coefficient of variation (CV), corneal thickness and volume, maximum keratometry, and anterior chamber volume and depth (ACD) measurements were performed using a specular microscope and Pentacam HR., Results: The mean duration of uveitis was 24.6 ± 40.5 (0-180) months. The mean number of uveitis attacks was 2.8 ± 3.0 (1-20). Coefficient of variation was significantly higher in the active uveitis group compared with inactive uveitis group (p=0.017, Post Hoc Tukey). Anterior segment parameters other than coefficient of variation were not significantly different between active/inactive uveitis and control groups (p>0.05). Multiple linear regression analysis showed that coefficient of variation was greater in active uveitis compared with inactive uveitis after adjusting for the duration of uveitis, type of uveitis, having a rheumatologic disease, and having immunosuppressive treatment (p=0.003). The duration of uveitis and number of attacks were not significantly correlated with ocular parameters (p>0.05, Spearman's correlation). The difference in parameters was not significant based on uveitis type (p>0.05)., Conclusions: Coefficient of variation was higher in eyes with active uveitis than that in eyes with inactive uveitis, whereas corneal endothelial cell density and anterior chamber morphology did not significantly differ between active/inactive uveitis and control groups.
- Published
- 2021
- Full Text
- View/download PDF
48. Automated macular segmentation with spectral domain optical coherence tomography in the fellow eyes of patients with unilateral retinal vein occlusion.
- Author
-
Cetin EN, Bozkurt K, Parca O, and Pekel G
- Subjects
- Female, Follow-Up Studies, Humans, Male, Middle Aged, Nerve Fibers pathology, Retrospective Studies, Macula Lutea pathology, Retinal Ganglion Cells pathology, Retinal Pigment Epithelium pathology, Retinal Vein Occlusion diagnosis, Tomography, Optical Coherence methods
- Abstract
Purpose: To assess the change in the macular layers in the fellow eyes of unilateral retinal vein occlusion (RVO) patients and to evaluate whether certain layers are more affected based on RVO type., Methods: This retrospective study included 87 fellow eyes of patients with unilateral RVO (26 central, 61 branch) and 105 eyes of 105 subjects without RVO. Spectral domain optical coherence tomography was used for automatized retinal segmentation. The thicknesses of retinal nerve fiber layer (RNFL), ganglion cells, inner plexiform, inner nuclear, outer plexiform, outer nuclear, photoreceptor layers, overall inner retinal layers and retinal pigment epithelium (RPE) were documented., Results: Inner plexiform layer was thinner in inferior sector in RVO group compared with the control group (p = 0.047). The subgroup analysis showed that the retina was thinner in RVO group compared with the controls without systemic diseases in some sectors of the following layers: inferior retina, RNFL, ganglion cell layer, inner plexiform layer, inner retinal layers and RPE (p < 0.05). Retinal thickness was decreased in the fellow eyes of branch RVO group compared to that in the central RVO group in the some sectors (p < 0.05)., Conclusions: The fellow eyes of unilateral RVO patients did not show major structural differences compared with the controls; however, they revealed significant sectoral thinning in many retinal layers when compared with the eyes of healthy subjects without systemic diseases. Central macula was thinner in the fellow eyes of patients with branch RVO compared to that in central RVO.
- Published
- 2019
- Full Text
- View/download PDF
49. Classification of Limbal Stem Cell Deficiency Using Clinical and Confocal Grading.
- Author
-
Aravena C, Bozkurt K, Chuephanich P, Supiyaphun C, Yu F, and Deng SX
- Subjects
- Adult, Aged, Aged, 80 and over, Corneal Diseases pathology, Cross-Sectional Studies, Female, Follow-Up Studies, Humans, Male, Middle Aged, Retrospective Studies, Severity of Illness Index, Young Adult, Corneal Diseases classification, Limbus Corneae pathology, Microscopy, Confocal methods, Stem Cells pathology
- Abstract
Purpose: To grade the severity of limbal stem cell deficiency (LSCD) based on the extent of clinical presentation and central corneal basal epithelial cell density (BCD)., Methods: This is a retrospective observational comparative study of 48 eyes of 35 patients with LSCD and 9 eyes of 7 normal subjects (controls). Confocal images of the central cornea were acquired. A clinical scoring system was created based on the extent of limbal and corneal surface involvement. LSCD was graded as mild, moderate, and severe stages based on the clinical scores. The degree of BCD reduction was given a score of 0 to 3., Results: Compared with BCD in controls, BCD decreased by 23.0%, 40.4%, and 69.5% in the mild, moderate, and severe stages of LSCD classified by the clinical scoring system, respectively. The degree of BCD reduction was positively correlated with larger limbal and corneal surface involvement and when the central visual axis was affected (all P ≤ 0.0005). Mean corrected distance visual acuity logarithm of the minimum angle of resolution was 0.0 ± 0.0 in control eyes, 0.2 ± 0.5 in mild LSCD, 0.6 ± 0.4 in moderate LSCD, and 1.6 ± 1.1 in severe LSCD (P < 0.0001). There was a significant correlation between a higher clinical score and corrected distance visual acuity logarithm of the minimum angle of resolution (rho = 0.82; P < 0.0001) and a greater decrease in BCD (rho = -0.78; P < 0.0001)., Conclusions: A clinical scoring system was developed to assess the extent of clinical presentation of LSCD. A classification system to grade the severity of LSCD can be established by combining the BCD score with the clinical score.
- Published
- 2019
- Full Text
- View/download PDF
50. New aspect for systemic effects of COPD: eye findings.
- Author
-
Ugurlu E, Pekel G, Altinisik G, Bozkurt K, Can I, and Evyapan F
- Subjects
- Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Visual Acuity, Choroid pathology, Nerve Fibers pathology, Pulmonary Disease, Chronic Obstructive pathology, Retina pathology, Tomography, Optical Coherence methods
- Abstract
Introduction: Chronic obstructive pulmonary disease (COPD) has multisystemic implications and comorbidities. Hypoxia and systemic inflammation are thought to involve oculary structures. In this study, our aim is to evaluate retinal nerve fiber and choroidal thickness and retinal vessel diameter using the spectral-domain optical coherence tomography (SD-OCT) in COPD subjects., Methods: Forty-three subjects diagnosed with COPD according to the Global Initiative for Chronic Obstructive Lung Disease criteria at the Pulmonology Department of Pamukkale University were enrolled in the study. All subjects underwent respiratory function testing and a carbon monoxide diffusion test. To determine hypoxic state, arterial blood gas analysis was performed. The control group consisted of 31 subjects with comparable age and gender distribution. All participants underwent a standard ophthalmic examination including visual acuity assessment, biomicroscopy, air-puff tonometry, indirect retinoscopy, and SD-OCT measurements., Results: The mean subfoveal choroidal thickness (SFCT), foveal thickness, and retinal arteriolar caliber were found to be similar in both groups, while the mean retinal venular caliber value was markedly higher in the COPD group. The mean peripapillary retinal nerve fiber layer (RNFL) thickness was 100.2±11.8 µm in the COPD group and 105.6 ± 8.1 µm in the control group (P = .03). The inferior quadrant RNFL was significantly thinner in the COPD group., Conclusions: The results of this study showed increasing diameter of the retinal veins, thinning of the RNFL, and SFCT may be associated to chronic inflammation and hypoxia in subjects with COPD. Future guidelines may include ocular findings to the present systemic manifestations of COPD., (© 2016 John Wiley & Sons Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.